BROWN FORMAN CORP, 10-K filed on 6/13/2025
Annual Report
v3.25.1
Document and Entity Information - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Jun. 09, 2025
Document Information [Line Items]    
Document Type 10-K  
Document Annual Report true  
Document Period End Date Apr. 30, 2025  
Current Fiscal Year End Date --04-30  
Document Transition Report false  
Entity File Number 001-00123  
Entity Registrant Name BROWN-FORMAN CORPORATION  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 61-0143150  
Entity Address, Address Line One 850 Dixie Highway  
Entity Address, City or Town Louisville,  
Entity Address, State or Province KY  
Entity Address, Postal Zip Code 40210  
City Area Code 502  
Local Phone Number 585-1100  
Entity Well-known Seasoned Issuer Yes  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
ICFR Auditor Attestation Flag true  
Document Financial Statement Error Correction [Flag] false  
Entity Public Float $ 14,700  
Documents Incorporated by Reference
Portions of Registrant’s Proxy Statement for use in connection with the Annual Meeting of Stockholders to be held on or about July 24, 2025, are incorporated by reference into Part III of this report.
 
Entity Central Index Key 0000014693  
Amendment Flag false  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus FY  
Class A Common Stock    
Document Information [Line Items]    
Title of 12(b) Security Class A Common Stock (voting), $0.15 par value  
Trading Symbol BFA  
Security Exchange Name NYSE  
Entity Common Stock, Shares Outstanding   169,143,808
Class B Common Stock    
Document Information [Line Items]    
Title of 12(b) Security Class B Common Stock (nonvoting), $0.15 par value  
Trading Symbol BFB  
Security Exchange Name NYSE  
Entity Common Stock, Shares Outstanding   303,608,875
1.20% senior notes, due July 7, 2026 [Member]    
Document Information [Line Items]    
Title of 12(b) Security 1.200% Notes due 2026  
Trading Symbol BF26  
Security Exchange Name NYSE  
2.60% senior notes, due July 7, 2028 [Member]    
Document Information [Line Items]    
Title of 12(b) Security 2.600% Notes due 2028  
Trading Symbol BF28  
Security Exchange Name NYSE  
v3.25.1
Audit Information
12 Months Ended
Apr. 30, 2025
Auditor Information [Abstract]  
Auditor Name Ernst & Young LLP
Auditor Location Louisville, Kentucky
Auditor Firm ID 42
v3.25.1
Consolidated Statements of Operations - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Income Statement [Abstract]      
Sales $ 5,056 $ 5,328 $ 5,372
Excise taxes 1,081 1,150 1,144
Net sales 3,975 4,178 4,228
Cost of sales 1,632 1,652 1,734
Gross profit 2,343 2,526 2,494
Advertising expenses 484 529 506
Selling, general, and administrative expenses 744 826 742
Total restructuring and other charges 60 0 0
Gain on business divestitures 0 (267) 0
Other expense (income), net (52) 24 119
Operating income 1,107 1,414 1,127
Non-operating postretirement expense 4 3 29
Interest income (17) (14) (9)
Interest expense 122 127 90
Equity method investment income and gain on sale (83) 0 0
Income before income taxes 1,081 1,298 1,017
Income taxes 212 274 234
Net income $ 869 $ 1,024 $ 783
Earnings per share:      
Basic (dollars per share) $ 1.84 $ 2.15 $ 1.63
Diluted (dollars per share) $ 1.84 $ 2.14 $ 1.63
v3.25.1
Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Statement of Comprehensive Income [Abstract]      
Net income $ 869 $ 1,024 $ 783
Other comprehensive income (loss), net of tax:      
Currency translation adjustments 19 (7) 135
Cash flow hedge adjustments (15) 0 (27)
Postretirement benefits adjustments (3) 21 9
Net other comprehensive income (loss) 1 14 117
Comprehensive income $ 870 $ 1,038 $ 900
v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Apr. 30, 2025
Apr. 30, 2024
ASSETS    
Cash and cash equivalents $ 444 $ 446
Accounts receivable, net 830 769
Inventories:    
Barreled whiskey 1,567 1,490
Finished goods 476 452
Work in process 378 396
Raw materials and supplies 90 218
Total inventories 2,511 2,556
Other current assets 289 265
Assets held for sale 121 0
Total current assets 4,195 4,036
Property, plant, and equipment, net 1,095 1,074
Goodwill 1,505 1,455
Other intangible assets 981 990
Equity method investments 3 270
Deferred tax assets 47 69
Other assets 260 272
Total assets 8,086 8,166
Liabilities    
Accounts payable and accrued expenses 741 793
Accrued income taxes 27 38
Short-term borrowings 312 428
Current portion of long-term debt 0 300
Total current liabilities 1,080 1,559
Long-term debt 2,421 2,372
Deferred tax liabilities 241 315
Accrued pension and other postretirement benefits 164 160
Other liabilities 187 243
Total liabilities 4,093 4,649
Commitments and contingencies
Stockholders’ Equity    
Additional paid-in capital 36 13
Retained earnings 4,710 4,261
Accumulated other comprehensive income (loss), net of tax (220) (221)
Treasury stock, at cost (11,932,000 and 11,863,000 shares in 2024 and 2025, respectively) (605) (608)
Total stockholders’ equity 3,993 3,517
Total liabilities and stockholders’ equity 8,086 8,166
Class A Common Stock    
Stockholders’ Equity    
Common stock 25 25
Class B Common Stock    
Stockholders’ Equity    
Common stock $ 47 $ 47
v3.25.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Apr. 30, 2025
Apr. 30, 2024
Treasury stock, shares (in shares) 11,863,000 11,932,000
Class A Common Stock    
Common stock, shares issued (in shares) 170,000,000 170,000,000
Common stock, shares authorized (in shares) 170,000,000 170,000,000
Common stock, par value (in dollars per share) $ 0.15 $ 0.15
Class B Common Stock    
Common stock, shares issued (in shares) 314,532,000 314,532,000
Common stock, shares authorized (in shares) 400,000,000 400,000,000
Common stock, par value (in dollars per share) $ 0.15 $ 0.15
v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Cash flows from operating activities:      
Net income $ 869 $ 1,024 $ 783
Adjustments to reconcile net income to net cash provided by operations:      
Gain on business divestitures 0 (267) 0
Equity method investment income and gain on sale (83) 0 0
Asset impairment charges 49 7 96
Depreciation and amortization 87 87 80
Stock-based compensation expense 28 25 18
Deferred income tax provision (benefit) (39) 18 (3)
Change in fair value of contingent consideration (43) 9 0
Other, net (17) 7 18
Changes in assets and liabilities, net of business acquisitions and divestitures:      
Accounts receivable (70) 88 (21)
Inventories (64) (349) (403)
Other current assets (25) 23 4
Accounts payable and accrued expenses (40) (31) 77
Accrued income taxes (13) 17 (57)
Other operating assets and liabilities (41) (11) 48
Cash provided by operating activities 598 647 640
Cash flows from investing activities:      
Proceeds from business divestitures 0 246 0
Proceeds from sale of equity method investment 350 0 0
Business acquisitions, net of cash acquired 0 0 (1,195)
Additions to property, plant, and equipment (167) (228) (183)
Other, net 66 31 23
Cash provided by (used for) investing activities 249 49 (1,355)
Cash flows from financing activities:      
Proceeds from short-term borrowings, maturities greater than 90 days 0 0 600
Repayments of short-term borrowings, maturities greater than 90 days 0 0 (600)
Net change in other short-term borrowings (117) 192 234
Repayment of long-term debt (300) 0 (250)
Proceeds from long-term debt 0 0 648
Acquisition of treasury stock 0 (400) 0
Dividends paid (420) (404) (378)
Other, net (6) (6) (15)
Cash provided by (used for) financing activities (843) (618) 239
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 3 (6) (14)
Net increase (decrease) in cash, cash equivalents, and restricted cash 7 72 (490)
Cash, cash equivalents, and restricted cash at beginning of period 456 384 874
Cash, cash equivalents, and restricted cash at end of period 463 456 384
Less: Restricted cash (included in other current assets) at end of period (19) (10) (10)
Cash and cash equivalents at end of period 444 446 374
Supplemental information:      
Cash paid for interest 119 125 85
Cash paid for income taxes 303 242 278
Non-cash additions to property, plant, and equipment $ 14 $ 20 $ 27
v3.25.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Millions
Total
Additional Paid-in Capital
Retained Earnings
AOCI
Treasury Stock
Class A Common Stock
Common Stock [Member]
Class B Common Stock
Common Stock [Member]
Beginning Balance at Apr. 30, 2022 $ 2,737 $ 0 $ 3,242 $ (352) $ (225) $ 25 $ 47
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 783   783        
Net other comprehensive income (loss) 117     117      
Cash dividends (378)   (378)        
Stock-based compensation expense 18 18          
Stock issued under compensation plans 12       12    
Loss on treasury stock issued under compensation plans (21) (17) (4)        
Ending Balance at Apr. 30, 2023 3,268 1 3,643 (235) (213) 25 47
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 1,024   1,024        
Net other comprehensive income (loss) 14     14      
Cash dividends (404)   (404)        
Acquisition of treasury stock (404)       (404)    
Stock-based compensation expense 25 25          
Stock issued under compensation plans 9       9    
Loss on treasury stock issued under compensation plans (15) (13) (2)        
Ending Balance at Apr. 30, 2024 3,517 13 4,261 (221) (608) 25 47
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 869   869        
Net other comprehensive income (loss) 1     1      
Cash dividends (420)   (420)        
Stock-based compensation expense 28 28          
Stock issued under compensation plans 3       3    
Loss on treasury stock issued under compensation plans (5) (5)          
Ending Balance at Apr. 30, 2025 $ 3,993 $ 36 $ 4,710 $ (220) $ (605) $ 25 $ 47
v3.25.1
Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Statement of Stockholders' Equity [Abstract]      
Cash dividends (dollars per share) $ 0.8886 $ 0.8466 $ 0.7880
v3.25.1
Accounting Policies
12 Months Ended
Apr. 30, 2025
Accounting Policies [Abstract]  
Accounting Policies Accounting Policies
We prepare our consolidated financial statements in conformity with accounting principles generally accepted in the United States (GAAP). We also apply the following accounting policies when preparing our consolidated financial statements:
Principles of consolidation. Our consolidated financial statements include the accounts of all subsidiaries in which we have a controlling financial interest. We use the equity method to account for investments in entities that we do not control but over whose operating and financial policies we have the ability to exercise significant influence. We eliminate all intercompany transactions.
Estimates. To prepare financial statements that conform with GAAP, our management must make informed estimates that affect how we report revenues, expenses, assets, and liabilities, including contingent assets and liabilities. Actual results could differ from these estimates.
Cash equivalents. Cash equivalents include bank demand deposits and all highly liquid investments with original maturities of three months or less.
Accounts receivable. Accounts receivable are recorded net of an allowance for expected credit losses (allowance for doubtful accounts). We determine the allowance using information such as customer credit history and financial condition, historical loss experience, and macroeconomic factors. We write off account balances against the allowance when we have exhausted our collection efforts. The allowance for doubtful accounts was $8 and $7 at April 30, 2024 and 2025, respectively.
Inventories. Inventories are valued at the lower of cost or net realizable value. Approximately 50% of our consolidated inventories are valued using the last-in, first-out (LIFO) cost method, which we use for the majority of our U.S. inventories. We value the remainder of our inventories primarily using the first-in, first-out (FIFO) cost method. FIFO cost approximates current replacement cost. If we had used the FIFO method for all inventories, they would have been $512 and $600 higher than reported at April 30, 2024 and 2025, respectively.
Because we age most of our whiskeys in barrels for three years or more, we bottle and sell only a portion of our whiskey inventory each year. Following industry practice, we classify all barreled whiskey as a current asset. We include warehousing, insurance, ad valorem taxes, and other carrying charges applicable to barreled whiskey in inventory costs.
We classify agave inventories, bulk tequila, barreled rum, and liquid in bottling tanks as work in process.
Property, plant, and equipment. We state property, plant, and equipment at cost less accumulated depreciation. We calculate depreciation on a straight-line basis using our estimates of useful life, which are 20–40 years for buildings and improvements; 3–10 years for machinery, equipment, vehicles, furniture, and fixtures; and 3–7 years for capitalized software.
We assess our property, plant, and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of those assets may not be recoverable. When we do not expect to recover the carrying value of an asset (or asset group) through undiscounted future cash flows, we write it down to its estimated fair value. We determine fair value using discounted estimated future cash flows, considering market values for similar assets when available.
When we retire or dispose of property, plant, and equipment, we remove its cost and accumulated depreciation from our balance sheet and reflect any gain or loss in operating income. We expense the costs of repairing and maintaining our property, plant, and equipment as we incur them.
Goodwill and other intangible assets. When we acquire a business, we first allocate the purchase price to identifiable assets and liabilities, including intangible brand names and trademarks (“brand names”), based on estimated fair value. We then record any remaining purchase price as goodwill. We do not amortize goodwill or other intangible assets with indefinite lives. We consider all of our brand names to have indefinite lives.
We assess our goodwill and other indefinite-lived intangible assets for impairment at least annually, or more frequently if circumstances indicate the carrying amount may be impaired. Goodwill is impaired when the carrying amount of the related reporting unit exceeds its estimated fair value, in which case we write down the goodwill by the amount of the excess (limited to the carrying amount of the goodwill). We estimate the reporting unit’s fair value using discounted estimated future cash flows or market information. Similarly, a brand name is impaired when its carrying amount exceeds its estimated fair value, in which case we write down the brand name to its estimated fair value. We estimate the fair value of a brand name using the
relief-from-royalty method. We also consider market values for similar assets when available. Considerable management judgment is necessary to estimate fair value, including the selection of assumptions about future cash flows, net sales, discount rates, and royalty rates.
We have the option, before quantifying the fair value of a reporting unit or brand name, to evaluate qualitative factors to assess whether it is more likely than not that our goodwill or brand names are impaired. If we determine that is not the case, then we are not required to quantify the fair value. That assessment also takes considerable management judgment.
Revenue recognition. Our net sales predominantly reflect global sales of beverage alcohol consumer products. We sell these products under contracts with different types of customers, depending on the market. The customer is most often a distributor, wholesaler, or retailer.
Each contract typically includes a single performance obligation to transfer control of the products to the customer. Depending on the contract, control is transferred when the products are either shipped or delivered to the customer, at which point we recognize the transaction price for those products as net sales. The transaction price recognized at that point reflects our estimate of the consideration to be received in exchange for the products. The actual amount may ultimately differ due to the effect of various customer incentives and trade promotion activities. In making our estimates, we consider our historical experience and current expectations, as applicable. Subsequent adjustments recognized for changes in estimated transaction prices are typically not material.
Net sales exclude taxes we collect from customers that are imposed by various governments on our sales, and are reduced by payments to customers unless made in exchange for distinct goods or services with fair values approximating the payments. Net sales include any amounts we bill customers for shipping and handling activities related to the products. We recognize the cost of those activities in cost of sales during the same period in which we recognize the related net sales. Sales returns, which are permitted only in limited situations, are not material. Customer payment terms generally range from 30 to 90 days. There are no significant amounts of contract assets or liabilities.
Cost of sales. Cost of sales includes the costs of receiving, producing, inspecting, warehousing, insuring, and shipping goods sold during the period.
Advertising costs. We expense the production costs of advertising when the advertisements first take place. We expense all other advertising costs during the year in which the costs are incurred.
Selling, general, and administrative expenses. Selling, general, and administrative expenses include the costs associated with our sales force, administrative staff and facilities, and other expenses related to our non-manufacturing functions.
Stock-based compensation. We use stock-based awards as part of our incentive compensation for eligible employees and directors. We recognize the grant-date fair value of an award as compensation expense on a straight-line basis over the requisite service period, which typically corresponds to the vesting period for the award. Upon forfeiture of an award prior to vesting, we reverse any previously recognized compensation expense related to that award. We classify stock-based compensation expense within selling, general, and administrative expenses.
As we recognize compensation expense for a stock-based award, we concurrently recognize a related deferred tax asset. The subsequent vesting or exercise of the award will generally result in an actual tax benefit that differs from the deferred tax asset that had been recorded. The excess (deficiency) of the actual tax benefit over (under) the previously recorded tax asset is recognized as income tax benefit (expense) on the date of vesting or exercise.
Income taxes. We base our annual provision for income taxes on the pre-tax income reflected in our consolidated statement of operations. We establish deferred tax liabilities or assets for temporary differences between GAAP and tax reporting bases and later adjust them to reflect changes in tax rates expected to be in effect when the temporary differences reverse. We record a valuation allowance as necessary to reduce a deferred tax asset to the amount that we believe is more likely than not to be realized. Certain income earned by foreign subsidiaries is subject to Global Intangible Low-Taxed Income (GILTI), a U.S. tax on foreign earnings. We treat the tax effect of GILTI as a current period tax expense when incurred. We do not provide deferred income taxes on undistributed earnings of foreign subsidiaries that we expect to indefinitely reinvest. We record a deferred tax charge in prepaid taxes for the difference between GAAP and tax reporting bases with respect to the elimination of intercompany profit in ending inventory.
We assess our uncertain income tax positions in two steps. First, we evaluate whether the tax position will, more likely than not, based on its technical merits, be sustained upon examination, including resolution of any related appeals or litigation. For a tax position that does not meet this first criterion, we recognize no tax benefit. For a tax position that does meet the first criterion, we recognize a tax benefit in an amount equal to the largest amount of benefit that we believe has more than a 50%
likelihood of being realized upon ultimate resolution. We record interest and penalties on uncertain tax positions as income tax expense.
Foreign currency transactions and translation. We report all gains and losses from foreign currency transactions (those denominated in a currency other than the entity’s functional currency) in current income. The U.S. dollar is the functional currency for most of our consolidated entities. The local currency is the functional currency for some of our consolidated foreign entities. We translate the financial statements of those foreign entities into U.S. dollars, using the exchange rate in effect at the balance sheet date to translate assets and liabilities, and using the average exchange rate for the reporting period to translate income and expenses. We record the resulting translation adjustments in other comprehensive income (loss).
Reclassifications: Certain prior year amounts have been reclassified to conform with the current year’s presentation.
Recently adopted accounting standard. In November 2023, the Financial Accounting Standards Board (FASB) issued an updated accounting standard requiring additional disclosures about significant segment expenses and other segment items. We adopted the updated standard as of April 30, 2025 (Note 20). Adoption had no material impact on our consolidated financial statements.
Accounting standards not yet adopted. In December 2023, the FASB issued an updated accounting standard requiring additional disclosures about income taxes, primarily related to the rate reconciliation and information about income taxes paid. We are required to adopt the new guidance beginning in fiscal 2026. The update can be applied either prospectively or retrospectively.
In November 2024, the FASB issued an updated accounting standard requiring disaggregation, in the notes to the financial statements, of expense line items in the income statement that include certain categories of expenses. We are required to adopt the updated standard for annual disclosures beginning in fiscal 2028, and for interim disclosures in fiscal 2029, with earlier adoption permitted. The update can be applied either prospectively or retrospectively.
We are currently evaluating the impact that adopting these accounting standards updates will have on our disclosures.
v3.25.1
Balance Sheet Information
12 Months Ended
Apr. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Information Balance Sheet Information
Supplemental information on our year-end balance sheets is as follows:
April 30,20242025
Property, plant, and equipment:
Land$49 49
Buildings782 841
Equipment928 869
Construction in process181 180
1,940 1,939 
Less accumulated depreciation866 844
$1,074 $1,095 
Accounts payable and accrued expenses:
Accounts payable, trade$267 $243 
Accrued expenses:
Advertising, promotion, and discounts200 197 
Compensation and commissions105 86 
Excise and other non-income taxes67 67 
Other154 148 
526 498 
$793 $741 
Other liabilities:
Contingent consideration
$69 $31 
Other174 156 
$243 $187 
April 30,20242025
Accumulated other comprehensive income (loss), net of tax:
Currency translation adjustments$(111)$(92)
Cash flow hedge adjustments10 (5)
Postretirement benefits adjustments(120)(123)
$(221)$(220)
v3.25.1
Earnings Per Share
12 Months Ended
Apr. 30, 2025
Earnings Per Share [Abstract]  
Earnings per Share Earnings per Share
We calculate basic earnings per share by dividing net income available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share further includes the dilutive effect of stock-based compensation awards. We calculate that dilutive effect using the “treasury stock method” (as defined by GAAP).
The following table presents information concerning basic and diluted earnings per share: 
202320242025
Net income available to common stockholders$783 $1,024 $869 
Share data (in thousands):
Basic average common shares outstanding479,155 476,394 472,655 
Dilutive effect of stock-based awards1,310 826 295 
Diluted average common shares outstanding480,465 477,220 472,950 
Basic earnings per share$1.63 $2.15 $1.84 
Diluted earnings per share$1.63 $2.14 $1.84 
We excluded common stock-based awards for approximately 1,107,000 shares, 1,689,000 shares, and 3,325,000 shares from the calculation of diluted earnings per share for 2023, 2024, and 2025, respectively, because they were not dilutive for those periods under the treasury stock method.
v3.25.1
Goodwill and Other Intangible Assets
12 Months Ended
Apr. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets
The following table shows the changes in goodwill (which include no accumulated impairment losses) and other intangible assets over the past two years: 
GoodwillOther Intangible Assets
Balance as of April 30, 2023
$1,457 $1,164 
Purchase accounting adjustments
40 (53)
Business divestitures
(28)(89)
Foreign currency translation adjustment(14)(25)
Impairment— (7)
Balance as of April 30, 2024
1,455 990 
Foreign currency translation adjustment50 38 
Impairment— (47)
Balance as of April 30, 2025
$1,505 $981 
Our other intangible assets consist of trademarks and brand names, all with indefinite useful lives.
During fiscal 2024, we recorded a $7 impairment charge related to the write-off of the carrying amount of an immaterial discontinued brand name. During the fourth quarter of fiscal 2025, in connection with the preparation of the consolidated financial statements, we recognized a non-cash impairment charge of $47 for the Gin Mare brand name, largely reflecting a decline in our financial forecast assumptions due to the more challenging macroeconomic environment in Europe (Note 17). The impairment charges are included in “other expense (income), net” in the accompanying consolidated statements of operations.
v3.25.1
Equity Method Investments
12 Months Ended
Apr. 30, 2025
Equity Method Investments and Joint Ventures [Abstract]  
Equity Method Investments Equity Method Investments
As of April 30, 2024, our equity method investments included a 21.4% ownership of the common stock of The Duckhorn Portfolio, Inc. (“Duckhorn”), which we obtained as partial consideration for our sale of the Sonoma-Cutrer wine business to Duckhorn (Note 15). The carrying amount of our investment in Duckhorn was $267 as of April 30, 2024, reflecting the fair value of the common stock, based on its quoted market price at the April 30, 2024 closing date of the transaction. Our other equity method investments are immaterial.
Also, effective April 30, 2024, we entered into a transition services agreement (TSA) with Duckhorn related to the sale of the Sonoma-Cutrer wine business. Our cost of sales in 2025 included $24 for Sonoma-Cuter products purchased from Duckhorn under the TSA. Fees earned for transition services provided to Duckhorn under the TSA were immaterial. Services related to the TSA ended on or about August 31, 2024.
On October 6, 2024, Duckhorn entered into a definitive agreement pursuant to which Duckhorn would be acquired by private equity funds. The transaction was completed on December 24, 2024. Upon completion of the transaction, we received cash of $350 in exchange for our 21.4% ownership interest in Duckhorn. As a result of the transaction, we recognized a $78 gain on sale of our investment in Duckhorn in 2025.
v3.25.1
Restructuring and Other Charges
12 Months Ended
Apr. 30, 2025
Restructuring and Related Activities [Abstract]  
Restructuring and Other Charges Restructuring and Other Charges
On January 13, 2025, our Board of Directors approved a plan to reduce our structural cost base and realign resources toward future sources of growth (Restructuring Initiative). This included reducing our worldwide headcount by approximately 12% and closing our Louisville-based Brown-Forman Cooperage. These actions were substantially implemented in fiscal 2025, with the remainder to be completed by the end of fiscal 2026.
We expect to incur aggregate charges of approximately $60 to $70 in connection with these actions, consisting primarily of approximately $27 to $32 in severance and other employee-related costs and approximately $33 to $38 in other restructuring costs, including costs related to the Louisville-based Brown-Forman Cooperage facility closure and consulting services associated with the restructuring actions. Through April 30, 2025, we recognized $48 of restructuring and other charges associated with these actions, comprising $46 in restructuring charges and $2 in asset impairments included in other charges. The remaining $12 in other charges represents costs associated with a special one-time early retirement benefit. We also recorded $3 in charges to adjust the carrying value of certain Brown-Forman Cooperage inventory to the amount we expect to realize upon disposal. These charges are included in cost of sales in our consolidated statement of operations. As of April 30, 2025, $27 of the charges to be settled in cash have been paid.
The following table summarizes the restructuring and other charges recognized in fiscal 2025:
Restructuring charges:
   Severance and other employee-related costs
$24 
   Other restructuring charges1
22 
Restructuring charges46 
Other charges2
14 
Total restructuring and other charges$60 
1Primarily represents one-time costs related to the cooperage facility closure, consulting services, and other miscellaneous exit costs.
2Represents $12 in costs associated with a special one-time early retirement benefit to qualifying U.S. employees and $2 in impairment charges on certain cooperage facility assets held for sale.

The charges we currently expect to incur in connection with the Restructuring Initiative are subject to a number of assumptions and risks, and actual results may differ materially. We may also incur other material charges not currently contemplated due to events that may occur as a result of, or in connection with, the Restructuring Initiative.
The following table summarizes the activity in our accrued restructuring costs:
Severance and Other Employee-Related CostsOther Restructuring ChargesTotal
Balance at April 30, 2024$— $— $— 
Costs incurred and charged to expense24 22 46 
Costs paid or otherwise settled(11)(16)(27)
Balance at April 30, 2025$13 $$19 
v3.25.1
Contingencies
12 Months Ended
Apr. 30, 2025
Commitments and Contingencies Disclosure [Abstract]  
Contingencies Contingencies
We operate in a litigious environment, and we are sued in the normal course of business. Sometimes plaintiffs seek substantial damages. Significant judgment is required in predicting the outcome of these suits and claims, many of which take years to adjudicate. We accrue estimated costs for a contingency when we believe that a loss is probable and we can make a reasonable estimate of the loss, and then adjust the accrual as appropriate to reflect changes in facts and circumstances. We do not believe it is reasonably possible that these existing loss contingencies, individually or in the aggregate, would have a material adverse effect on our financial position, results of operations, or liquidity. No material accrued loss contingencies are recorded as of April 30, 2025.
v3.25.1
Debt and Credit Facilities
12 Months Ended
Apr. 30, 2025
Debt Disclosure [Abstract]  
Debt and Credit Facilities Debt and Credit Facilities
Our long-term debt (net of unamortized discounts and issuance costs) consisted of:
April 30,20242025
3.50% senior notes, $300 principal amount, due April 15, 2025
$300 $— 
1.20% senior notes, €300 principal amount, due July 7, 2026
321 342 
2.60% senior notes, £300 principal amount, due July 7, 2028
375 401 
4.75% senior notes, $650 principal amount, due April 15, 2033
643 644 
4.00% senior notes, $300 principal amount, due April 15, 2038
295 296 
3.75% senior notes, $250 principal amount, due January 15, 2043
248 248 
4.50% senior notes, $500 principal amount, due July 15, 2045
490 490 
2,672 2,421 
Less current portion300 — 
$2,372 $2,421 
We repaid the $300 principal amount of 3.50% notes on their maturity date of April 15, 2025.
Debt payments required over the next five fiscal years consist of $0 in 2026, $342 in 2027, $0 in 2028, $402 in 2029, $0 in 2030, and $1,700 after 2030.
The senior notes contain terms, events of default, and covenants customary of these types of unsecured securities, including limitations on the amount of secured debt we can issue.
Details of our short-term borrowings at April 30, 2024 and 2025, are presented below:
April 30,20242025
Commercial paper (par amount)
$429$313
Average interest rate5.49%4.64%
Average remaining days to maturity1212
We have a committed revolving credit agreement with various U.S. and international banks for $900 that expires in May 2029. At April 30, 2025, there were no borrowings outstanding under this facility.
v3.25.1
Common Stock
12 Months Ended
Apr. 30, 2025
Common Stock [Abstract]  
Common Stock Common Stock
The following table shows the change in outstanding common shares during each of the last three years:
(Shares in thousands)Class AClass BTotal
Balance at April 30, 2022
169,175 309,845 479,020 
Stock issued under compensation plans65 231 296 
Balance at April 30, 2023
169,240 310,076 479,316 
Acquisition of treasury stock(176)(6,736)(6,912)
Stock issued under compensation plans44 152 196 
Balance at April 30, 2024
169,108 303,492 472,600 
Stock issued under compensation plans21 48 69 
Balance at April 30, 2025
169,129 303,540 472,669 
v3.25.1
Net Sales
12 Months Ended
Apr. 30, 2025
Net Sales [Abstract]  
Net Sales Net Sales
The following table shows our net sales by geography:
202320242025
United States
$1,968 $1,889 $1,765 
Developed International1
1,178 1,154 1,090 
Emerging2
824 869 852 
Travel Retail3
170 179 166 
Non-branded and bulk4
88 87 102 
$4,228 $4,178 $3,975 
1Represents net sales of branded products to “advanced economies” as defined by the International Monetary Fund (IMF), excluding the United States. Our top developed international markets are Germany, Australia, the United Kingdom, France, and Canada.
2Represents net sales of branded products to “emerging and developing economies” as defined by the IMF. Our top emerging markets are Mexico, Poland, Brazil, and Türkiye.
3Represents net sales of branded products to global duty-free customers, other travel retail customers, and the U.S. military, regardless of customer location.
4Includes net sales of used barrels, contract bottling services, and non-branded bulk whiskey, regardless of customer location.

The following table shows our net sales by product category:
202320242025
Whiskey1
$2,915 $2,832 $2,828 
Ready-to-Drink2
509 520 491 
Tequila3
320 306 262 
Non-branded and bulk4
88 87 102 
Rest of portfolio5
396 433 292 
$4,228 $4,178 $3,975 
1Includes all whiskey spirits and whiskey-based flavored liqueurs. The brands included in this category are the Jack Daniel’s family of brands (excluding the “Ready-to-Drink” products outlined below), the Woodford Reserve family of brands, the Old Forester family of brands, The Glendronach, Benriach, Glenglassaugh, and Slane Irish Whiskey.
2Includes the Jack Daniel’s ready-to-drink (RTD) and ready-to-pour (RTP) products, New Mix, and other RTD/RTP products.
3Includes el Jimador, the Herradura family of brands, and other tequilas.
4Includes net sales of used barrels, contract bottling services, and non-branded bulk whiskey.
5Includes Korbel California Champagnes and Korbel Brandy (announced the end of the sales, marketing, and distribution relationship effective June 30, 2025), Diplomático, Chambord, Gin Mare, Sonoma-Cutrer (which was divested on April 30, 2024), Finlandia Vodka (which was divested on November 1, 2023), Fords Gin, and other agency brands (brands we do not own, but sell in certain markets).
v3.25.1
Pension and Other Postretirement Benefits
12 Months Ended
Apr. 30, 2025
Retirement Benefits [Abstract]  
Pension and Other Postretirement Benefits Pension and Other Postretirement Benefits
We sponsor various defined benefit pension plans as well as postretirement plans providing retiree health care and retiree life insurance benefits. Below, we discuss our obligations related to these plans, the assets dedicated to meeting the obligations, and the amounts we recognized in our financial statements as a result of sponsoring these plans.
 
Obligations. We provide eligible employees with pension and other postretirement benefits based on factors such as years of service and compensation level during employment. The pension obligation shown below (“projected benefit obligation”) consists of: (a) benefits earned by employees to date based on current salary levels (“accumulated benefit obligation”); and (b) benefits to be received by employees as a result of expected future salary increases. (The obligation for medical and life insurance benefits is not affected by future salary increases.) The following table shows how the present value of our projected benefit obligations changed during each of the last two years. 
 Pension BenefitsMedical and Life
Insurance Benefits
 2024202520242025
Obligation at beginning of year$731 $679 $40 $36 
Service cost18 16 — — 
Interest cost34 35 
Net actuarial loss (gain)1
(61)(3)
Plan amendments— — — 
Retiree contributions— — 
Benefits paid(44)(52)(6)(5)
Special termination benefits— — — 
Obligation at end of year$679 $683 $36 $39 
1 The net actuarial loss (gain) during each year was primarily attributable to changes in discount rates.
Service cost represents the present value of the benefits attributed to service rendered by employees during the year. Interest cost is the increase in the present value of the obligation due to the passage of time. Net actuarial loss (gain) is the change in value of the obligation resulting from experience different from that assumed or from a change in an actuarial assumption. (We discuss actuarial assumptions used at the end of this note.) Plan amendments can also change the value of the obligation.
As shown in the previous table, the change in the value of our pension and other postretirement benefit obligations also includes the effect of benefit payments and retiree contributions. Expected benefit payments (net of retiree contributions) over the next 10 years are as follows:
Pension BenefitsMedical and Life
Insurance Benefits
2026$105 $
202750 
202851 
202952 
203052 
2031 – 2035260 15 
Assets. We invest in specific assets to fund our pension benefit obligations. Our investment goal is to earn a total return that, over time, will grow assets sufficiently to fund our plans’ liabilities, after providing appropriate levels of contributions and accepting prudent levels of investment risk. To achieve this goal, plan assets are invested primarily in funds or portfolios of funds managed by outside managers. Investment risk is managed by company policies that require diversification of asset classes, manager styles, and individual holdings. We measure and monitor investment risk through quarterly and annual performance reviews, and through periodic asset/liability studies.
Asset allocation is the most important method for achieving our investment goals and is based on our assessment of the plans’ long-term return objectives and the appropriate balances needed for liquidity, stability, and diversification. As of April 30, 2025, our target asset allocation is a mix of 26% public equity investments, 59% fixed income investments, and 15% alternative investments.
The following table shows the fair value of pension plan assets by category as of the end of the last two years. (Fair value levels are defined in Note 17.)
 Level 1Level 2Level 3Total
April 30, 2024
Equity securities$31 $— $— $31 
Fixed income investments
— 278 — 278 
Limited partnership interest1
— — 
$31 $278 $310 
Investments measured at net asset value:
Commingled trust funds2:
Equity funds118 
Fixed income funds53 
Real estate fund49 
Short-term investments11 
Limited partnership interests3
38 
Net receivable (payable) for pending transactions
(3)
Total$576 
April 30, 2025
Equity securities$25 $— $— $25 
Fixed income investments— 242 — 242 
Limited partnership interest1
— — 
$25 $242 $268 
Investments measured at net asset value:
Commingled trust funds2:
Equity funds115 
Fixed income funds28 
Real estate fund41 
Short-term investments75 
Limited partnership interests3
47 
Net receivable (payable) for pending transactions
Total$576 
1 This limited partnership interest was initially valued at cost and has been adjusted to fair value as determined in good faith by management of the partnership using various factors, and does not meet the requirements for reporting at the net asset value (NAV). The valuation requires significant judgment due to the absence of quoted market prices and the inherent lack of liquidity. This limited partnership has a term expiring in September 2025.
2 Commingled trust fund valuations are based on the NAV of the funds as determined by the fund administrators and reviewed by us. NAV represents the underlying assets owned by the fund, minus liabilities and divided by the number of shares or units outstanding. Generally, for commingled trust funds other than real estate, redemptions are permitted daily with no notice period. The real estate fund is redeemable quarterly with 110 days’ notice.
3 These limited partnership interests were initially valued at cost and have been adjusted using NAV per audited financial statements. Investments are generally not eligible for immediate redemption and have original terms averaging 10 to 13 years, although those periods may be extended.
The following table shows how the total fair value of all pension plan assets changed during each of the last two years. (We do not have assets set aside for postretirement medical or life insurance benefits.) 
 Pension BenefitsMedical and Life
Insurance Benefits
 2024202520242025
Assets at beginning of year$606 $576 $— $— 
Actual return on assets(2)36 — — 
Retiree contributions— — 
Company contributions16 16 
Benefits paid(44)(52)(6)(5)
Assets at end of year$576 $576 $— $— 
We currently expect to contribute $16 to our pension plans and $4 to our postretirement medical and life insurance benefit plans during 2026.
Funded status. The funded status of a plan refers to the difference between its assets and its obligations. The following table shows the funded status of our plans.
 Pension BenefitsMedical and Life
Insurance Benefits
April 30,2024202520242025
Assets$576 $576 $— $— 
Obligations(679)(683)(36)(39)
Funded status$(103)$(107)$(36)$(39)
The funded status is recorded on the accompanying consolidated balance sheets as follows: 
 
Pension Benefits
Medical and Life
Insurance Benefits
April 30,2024202520242025
Other assets$32 $31 $— $— 
Accounts payable and accrued expenses(8)(9)(3)(4)
Accrued pension and other postretirement benefits(127)(129)(33)(35)
Net liability$(103)$(107)$(36)$(39)
Accumulated other comprehensive income (loss), before tax:
Net actuarial gain (loss)$(166)$(171)$$— 
Prior service credit (cost)(4)(2)
$(170)$(173)$$
The following table compares our pension plans whose accumulated benefit obligations exceed their assets with our pension plans whose assets exceed their accumulated benefit obligations.
 Accumulated
Benefit Obligation
Plan Assets
April 30,2024202520242025
Plans with accumulated benefit obligation in excess of assets$(124)$(128)$— $— 
Plans with assets in excess of accumulated benefit obligation(487)(507)576 576 
Total$(611)$(635)$576 $576 
The following table compares our pension plans whose projected benefit obligations exceed their assets with our pension plans whose assets exceed their projected benefit obligations.
 Projected
Benefit Obligation
Plan Assets
April 30,2024202520242025
Plans with projected benefit obligation in excess of assets$(135)$(138)$— $— 
Plans with assets in excess of projected benefit obligation(544)(545)576 576 
Total$(679)$(683)$576 $576 
As noted above, we have no assets set aside for the postretirement medical or life insurance benefit plans.
Pension cost. The following table shows the components of the pension cost recognized during each of the last three years. The amount for each year includes amortization of the prior service cost/credit and net actuarial loss/gain included in accumulated other comprehensive loss as of the beginning of the year. 
 Pension Benefits
 202320242025
Service cost$20 $18 $16 
Interest cost32 34 35 
Expected return on assets(43)(40)(38)
Amortization of:
Prior service cost (credit)
Net actuarial loss (gain)
Curtailment charge
— — 
Settlement charge29 — — 
Net cost$48 $19 $18 
We determine the expected return on plan assets by applying our long-term rate of return assumption to the market-related value of plan assets, adjusted by earnings on contributions and benefit payments expected to be made during the year. We calculate the market-related value of plan assets by amortizing actual versus expected returns over five years.
We amortize prior service costs and net actuarial gains or losses on straight-line basis over the average remaining service period of the employees expected to receive benefits under the plan. However, for net actuarial gains or losses, we use a corridor approach that amortizes them only to the extent the gain or loss exceeds 10% of the greater of the projected benefit obligation or market-related value of plan assets.
The settlement charge recognized during 2023 was triggered by fiscal year-to-date lump-sum payments under certain pension plans surpassing total annual service and interest cost for those plans.
Other postretirement benefits cost. The following table shows the components of the postretirement medical and life insurance benefits cost that we recognized during each of the last three years. 
 Medical and Life Insurance Benefits
 202320242025
Service cost$$— $— 
Interest cost
Curtailment charge
— — 
Net cost$$$
We amortize prior service costs and net actuarial gains or losses on straight-line basis over the average remaining service period of the employees expected to receive benefits under the plan.
Other comprehensive income (loss). We recognize prior service cost/credit and net actuarial loss/gain in other comprehensive income or loss (OCI) during the period in which they arise. These amounts are later amortized from accumulated OCI into pension and other postretirement benefit cost over future periods as described above. The following table shows the pre-tax effect of these amounts on OCI during each of the last three years.
 Pension BenefitsMedical and Life
Insurance Benefits
 202320242025202320242025
Prior service credit (cost)$— $(1)$— $— $— $— 
Net actuarial gain (loss)(29)20 (6)(2)
Amortization reclassified to earnings:
Prior service cost (credit)— — (1)
Net actuarial loss (gain)38 — — — 
Net amount recognized in OCI$10 $26 $(3)$$$(3)
Assumptions and sensitivity. We use various assumptions to determine the obligations and cost related to our pension and other postretirement benefit plans. The weighted-average assumptions used in computing benefit plan obligations as of the end of the last two years were as follows:
 
Pension Benefits
Medical and Life
Insurance Benefits
 2024202520242025
Discount rate5.70 %5.62 %5.66 %5.45 %
Rate of salary increase4.00 %4.00 %n/an/a
Interest crediting rate4.79 %4.69 %n/an/a
 
The weighted-average assumptions used in computing benefit plan cost during each of the last three years were as follows: 
 Pension BenefitsMedical and Life
Insurance Benefits
 202320242025202320242025
Discount rate for service cost4.52 %4.98 %5.74 %4.50 %5.02 %5.73 %
Discount rate for interest cost4.12 %4.79 %5.53 %3.96 %4.78 %5.49 %
Rate of salary increase4.00 %4.00 %4.00 %n/an/an/a
Interest crediting rate3.06 %3.69 %4.79 %n/an/an/a
Expected return on plan assets6.25 %6.50 %6.56 %n/an/an/a
We determine the assumed discount rates using a yield curve based on the interest rates of high-quality debt securities with maturities corresponding to the expected timing of our benefit payments. We measure the service cost and interest cost components by applying the specific spot rates along the yield curve used to measure the benefit obligation at the beginning of the period.
The assumed rate of salary increase reflects the expected average annual increase in salaries as a result of inflation, merit increases, and promotions over the service period of the plan participants.
The assumed interest crediting is based on the greater of the average yield on 30-year Treasury bonds or the minimum rate specified in the applicable pension plan.
The expected return on plan assets represents the long-term rate of return that we assume will be earned over the life of the pension assets. The assumption reflects expected capital market returns for each asset class, which are based on historical returns, adjusted for the expected effects of diversification.
The assumed health care cost trend rates as of the end of the last two years were as follows: 
 Medical and Life
Insurance Benefits
 20242025
Health care cost trend rate assumed for next year7.13 %8.54 %
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)4.50 %4.50 %
Year that the rate reaches the ultimate trend rate20322034
Savings plans. We also sponsor various defined contribution benefit plans that together cover substantially all U.S. employees. Employees can make voluntary contributions in accordance with their respective plans, which include a 401(k) tax deferral option. We match a percentage of each employee’s contributions in accordance with plan terms. We expensed $14, $14, and $13 for matching contributions during 2023, 2024, and 2025, respectively.
International plans. The information presented above for defined benefit plans and defined contribution benefit plans reflects amounts for U.S. plans only. Information about similar international plans is not presented due to immateriality.
v3.25.1
Stock-Based Compensation
12 Months Ended
Apr. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
The Brown-Forman 2022 Omnibus Compensation Plan (Plan) is our incentive compensation plan, designed to reward participants (including eligible executive officers, other employees, and non-employee directors) for company performance. Under the Plan, we can grant stock-based incentive awards for up to 12,412,433 shares of common stock to eligible participants until July 28, 2032. As of April 30, 2025, awards for approximately 10,640,000 shares remain available for issuance under the Plan. We try to limit the source of shares delivered to participants under the Plan to treasury shares that we purchase from time to time on the open market (in connection with a publicly announced share repurchase program), in private transactions, or otherwise.
Awards granted under the Plan include stock-settled stock appreciation rights (SSARs), performance-based restricted stock units (PBRSUs), time-based restricted stock units (RSUs), and deferred stock units (DSUs).
SSARs. We grant SSARs at an exercise price equal to the closing market price of the underlying stock on the grant date. SSARs become exercisable after three years from the first day of the fiscal year of grant and generally are exercisable for seven years after that date. The following table presents information about SSARs outstanding as of April 30, 2025, and for the year then ended.
Number of
SSARs
(in thousands)
Weighted-
Average
Exercise Price
per SSAR
Weighted-
Average
Remaining
Contractual
Term (years)
Aggregate
Intrinsic Value
Outstanding at April 30, 2024
3,750 $55.37 
Granted595 44.97 
Exercised(19)39.58 
Forfeited or expired(448)42.98 
Outstanding at April 30, 2025
3,878 $55.29 4.6$— 
Exercisable at April 30, 2025
2,653 $53.25 3.1$— 
We use the Black-Scholes pricing model to calculate the grant-date fair value of a SSAR. The weighted-average grant-date fair values and related valuation assumptions for the SSARS granted during each of the last three years were as follows:
202320242025
Grant-date fair value$20.67 $21.69 $12.86 
Valuation assumptions:
Expected term (years)7.07.07.0
Risk-free interest rate2.7 %4.1 %4.1 %
Expected volatility24.8 %25.0 %26.1 %
Expected dividend yield1.0 %1.2 %1.9 %
The expected term is based on past exercise experience for similar awards. The risk-free interest rate is based on zero-coupon U.S. Treasury rates as of the date of grant. Expected volatility and dividend yield are based on historical data, with consideration of other factors when applicable.
PBRSUs. The PBRSUs vest at the end of a three-year performance period that begins on the first day of the fiscal year of grant. For PBRSUs granted in fiscal 2023, performance is measured in full by comparing the three-year cumulative total shareholder return (TSR) of our Class B common stock to the three-year cumulative TSR of the companies in the Standard & Poor’s Consumer Staples Index (the peer group). Beginning with PBRSUs granted in fiscal 2024, performance is measured based in part (50%) on our TSR compared to the TSR of a specified peer group and in part (50%) on our adjusted operating income growth compared to the adjusted operating income growth of the peer group over the three-year performance period. At the end of the performance period, the number of PBRSUs is adjusted for performance, and then adjusted upward to account for
dividends paid during the second and third years of the performance period. The resulting PBRSUs are then converted to common shares.
The following table presents information about PBRSUs outstanding as of April 30, 2025, and for the year then ended.
Number of
PBRSUs
(in thousands)
Weighted-
Average
Fair Value at
Grant Date
Outstanding at April 30, 2024413 $76.53 
Granted356 $42.09 
Adjusted for performance and dividends(50)$70.04 
Converted to common shares(54)$70.04 
Forfeited(27)$48.81 
Outstanding at April 30, 2025638 $59.53 
For the portion of the PBRSUs based on adjusted operating income performance, we calculate the grant-date fair value using the closing market price on the underlying stock at the date of grant, discounted for dividends that are not paid on the PBRSUs during the first year of the performance period.
For the portion of the PBRSUs based on TSR, we calculate the grant-date fair value using a Monte Carlo simulation model. The following table shows the assumptions used in the Monte Carlo simulation model to value the awards granted during each of the last three fiscal years.
202320242025
Valuation assumptions:
Risk-free interest rate2.8 %4.6 %4.3 %
Expected volatility29.8 %22.2 %24.6 %
Expected dividend yield1.0 %1.2 %1.9 %
Remaining performance period (years) as of grant date2.82.82.8
RSUs. Beginning in fiscal 2024, we grant time-based restricted stock units (RSUs) to certain non-executive employees. Each RSU represents the right to receive one share of Class B common stock. The RSUs vest in three equal amounts at the end of each of the subsequent three fiscal years. Outstanding RSUs are credited with dividend-equivalent RSUs when dividends are paid on our common stock. The grant-date fair value of an RSU is the closing market price of the underlying stock on the grant date. The following table presents information about RSUs outstanding as of April 30, 2025, and for the year then ended.
Number of
RSUs
(in thousands)
Weighted-
Average
Fair Value at
Grant Date
Outstanding at April 30, 202487 $68.88 
Granted157 $44.65 
Additions for dividend equivalents$53.38 
Converted to common shares(30)$68.28 
Forfeited(10)$45.83 
Outstanding at April 30, 2025208 $51.51 
DSUs. DSUs are granted to our non-employee directors. Each DSU represents the right to receive one share of common stock based on the closing price of the shares on the date of grant. Outstanding DSUs are credited with dividend-equivalent DSUs when dividends are paid on our common stock. Each annual grant vests after one year. DSUs are paid out in shares after the completion of a director’s tenure on the board plus a six-month waiting period. The director may elect to receive the distribution either in a single lump sum or in ten equal annual installments. As of April 30, 2025, there were approximately 215,000 outstanding DSUs, of which approximately 180,000 were vested.
The grant-date fair value of a DSU is the closing market price of the underlying stock on the grant date. The weighted average grant-date fair values for these awards granted during each of the last three years were as follows:
202320242025
Grant-date fair value$72.10 $71.23 $45.99 
Additional information. The pre-tax stock-based compensation expense and related deferred income tax benefits recognized during the last three fiscal years were as follows:
202320242025
Pre-tax compensation expense$18 $25 $28 
Deferred tax benefit
As of April 30, 2025, there was $15 of total unrecognized compensation cost related to non-vested stock-based awards. That cost is expected to be recognized over a weighted-average period of 1.5 years. Further information related to our stock-based awards for the last three years is as follows:
202320242025
Intrinsic value of SSARs exercised$19 $12 $— 
Fair value of shares vested
Tax benefit from exercise / vesting of awards
v3.25.1
Income Taxes
12 Months Ended
Apr. 30, 2025
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
We incur income taxes on the earnings of our U.S. and foreign operations. The following table, based on the locations of the taxable entities from which sales were derived (rather than the location of customers), presents the U.S. and foreign components of our income before income taxes:
202320242025
United States$841 $917 $826 
Foreign176 381 255 
$1,017 $1,298 $1,081 
The income shown above was determined according to GAAP. Because those standards sometimes differ from the tax rules used to calculate taxable income, there are differences between (a) the amount of taxable income and pretax financial income for a year and (b) the tax bases of assets or liabilities and their amounts as recorded in our financial statements. As a result, we recognize a current tax liability for the estimated income tax payable on the current tax return, deferred tax liabilities (tax on income that will be recognized on future tax returns), and deferred tax assets (tax from deductions that will be recognized on future tax returns) for the estimated effects of the differences mentioned above.
Total income tax expense for a year includes the tax associated with the current tax return (current tax expense) and the change in the net deferred tax asset or liability (deferred tax expense). Our total income tax expense for each of the last three years was as follows:
202320242025
Current:
U.S. federal$157 $150 $173 
Foreign46 81 73 
State and local34 25 
237 256 251 
Deferred:
U.S. federal(4)16 (45)
Foreign(5)19 
State and local(5)(13)
(3)18 (39)
$234 $274 $212 
Our consolidated effective tax rate usually differs from current statutory rates due to the recognition of amounts for events or transactions with no tax consequences. The following table reconciles our effective tax rate to the federal statutory tax rate in the United States: 
 Percent of Income Before Taxes
 202320242025
U.S. federal statutory rate21.0 %21.0 %21.0 %
State taxes, net of U.S. federal tax benefit2.5 %1.3 %1.7 %
Income taxed at other than U.S. federal statutory rate3.0 %0.5 %1.5 %
Prior intercompany sales taxed at higher than current U.S. federal statutory rate1.0 %— %— %
Tax benefit from foreign-derived sales(3.0 %)(1.7 %)(2.8)%
Business divestitures
— %(0.7 %)— %
Adjustments related to prior years(0.5 %)— %(1.7)%
Excess tax benefits from stock-based awards(0.3 %)(0.1 %)— %
Tax rate changes— %0.4 %— %
Valuation allowance(1.3 %)0.1 %1.4 %
Other, net0.6 %0.4 %(1.5)%
Effective rate23.0 %21.2 %19.6 %
Deferred tax assets and liabilities as of the end of each of the last two years were as follows:
April 30,20242025
Deferred tax assets:
Postretirement and other benefits$65 $65 
Accrued liabilities and other29 44 
Inventories26 42 
Lease liabilities27 27 
Derivative instruments— 
Loss and credit carryforwards65 57 
Interest expense limitation carryforwards
18 23 
Total deferred tax assets230 260 
Valuation allowance(16)(35)
Total deferred tax assets, net of valuation allowance214 225 
Deferred tax liabilities:
Intangible assets(295)(294)
Property, plant, and equipment(93)(96)
Right-of-use assets(27)(27)
Derivative instruments(3)— 
Equity method investments
(37)— 
Other(5)(2)
Total deferred tax liabilities(460)(419)
Net deferred tax liability$(246)$(194)
Details of the loss, credit, and interest expense limitation carryforwards and related valuation allowances as of the end of each of the last two years are as follows:
April 30, 2024April 30, 2025
Gross AmountDeferred Tax AssetValuation AllowanceGross AmountDeferred Tax AssetValuation Allowance
Loss and credit carryforwards:
U.S.$110 $38 $(7)$68 $31 
1
$(10)
Foreign161 27 (9)135 26 
2
(15)
271 65 (16)203 57 (25)
Interest expense limitation carryforwards:
Foreign
74 18 — 91 23 
3
(10)
Total carryforwards
$345 $83 $(16)$294 $80 $(35)
1As of April 30, 2025, the deferred tax asset amount includes credit carryforwards of $12 that do not expire and loss and credit carryforwards of $19 that expire in varying amounts from 2026 to 2050.
2As of April 30, 2025, the deferred tax asset includes loss carryforwards of $23 that do not expire and $3 that expire in varying amounts over the next 10 years.
3The interest expense limitation carryforwards do not expire.
As of April 30, 2025, we had approximately $1,890 of undistributed earnings from our foreign subsidiaries ($1,909 at April 30, 2024). These earnings have been previously subject to tax, primarily as a result of the 2017 Tax Cuts and Jobs Act. Historically, we have asserted that the undistributed earnings of our foreign subsidiaries are reinvested indefinitely outside the United States. We continue to maintain indefinite reinvestment assertions for most undistributed earnings of our foreign subsidiaries, and no deferred taxes have been provided on the earnings. For undistributed earnings not considered permanently reinvested, deferred tax liabilities have been provided for any applicable income taxes and withholding taxes payable in various countries, which are not significant. We have also asserted that other outside basis differences related to our foreign subsidiaries are reinvested indefinitely and that the determination of any unrecognized deferred tax liabilities is not practicable due to the complexities in the calculations. The other outside basis differences relate primarily to differences between U.S. GAAP and tax basis that arose through purchase accounting. These basis differences could reverse through sales of foreign subsidiaries or other transactions, none of which are considered probable as of April 30, 2025.
At April 30, 2025, we had $13 of gross unrecognized tax benefits, $11 of which would reduce our effective income tax rate if recognized. A reconciliation of the beginning and ending unrecognized tax benefits follows: 
202320242025
Unrecognized tax benefits at beginning of year$14 $21 $14 
Additions for tax positions provided in prior periods— 
Additions for tax positions provided in current period
Decreases for tax positions provided in prior years— (3)— 
Settlements of tax positions in the current period— (3)— 
Lapse of statutes of limitations(4)(4)(3)
Unrecognized tax benefits at end of year$21 $14 $13 
We file federal income tax returns in the United States and also file tax returns in various state, local and foreign jurisdictions. The major jurisdictions where we are subject to examination by tax authorities include the United States, Brazil, Korea, Mexico, Netherlands, and the United Kingdom. We have tax years open for examination from 2013 and forward. Various tax examinations are currently in progress in the United States, for both federal and states, and in certain foreign jurisdictions. In the United States, we are participating in the Internal Revenue Service’s Compliance Assurance Program for our fiscal 2025 tax year.
We believe there will be no material change in our gross unrecognized tax benefits in the next 12 months.
v3.25.1
Acquisitions
12 Months Ended
Apr. 30, 2025
Acquisitions [Abstract]  
Acquisitions Acquisitions
Gin Mare. On November 3, 2022, we acquired the Gin Mare and Gin Mare Capri brands through our purchase of 100% of the equity interests of Gin Mare Brand, S.L.U., a Spanish company, and Mareliquid Vantguard, S.L.U., a Spanish company (the “Gin Mare acquisition”). The acquisition was accounted for as a business combination. The purchase price of the Gin Mare acquisition was $523, which consisted of $468 in cash paid at the acquisition date plus contingent consideration of $55.
The contingent consideration of $55 reflects the estimated fair value, at the acquisition date, of contingent future cash payments of up to €90 to the sellers under an “earn-out” provision of the acquisition agreement. We determined the estimated fair value of the contingent consideration using a Monte Carlo simulation, which requires the use of assumptions, such as projected future net sales, discount rates, and volatility rates.
Any contingent consideration earned by the sellers will become payable in cash upon exercise by the sellers of the right to receive the payment, which can occur no later than July 2027. The amount payable will depend on the achievement of net sales targets for Gin Mare for the latest fiscal year completed prior to the date of exercise by the sellers. The possible payments range from zero to €90. See Note 17 for additional information about the contingent consideration liability.
At the acquisition date, we also entered into a supply agreement with the sellers for the production and supply of Gin Mare products to us, at market terms, for an initial period of 10 years (subject to subsequent renewal periods).
Diplomático. On January 5, 2023, we acquired the Diplomático and Botucal rum brands through our purchase of (i) 100% of the equity interests of (a) International Rum and Spirits Distributors Unipessoal, Lda., a Portuguese company, (b) Diplomático Branding Unipessoal Lda., a Portuguese company, (c) International Bottling Services, S.A., a Panamanian corporation, and (d) International Rum & Spirits Marketing Solutions, S.L., a Spanish company; and (ii) certain assets of Destilerias Unidas Corp. (the “Diplomático acquisition”). The acquisition was accounted for as a business combination. The purchase price of the Diplomático acquisition consisted of cash of $723 (net of a post-closing working capital adjustment of $4).
At the acquisition date, we also entered into a supply agreement with the sellers for their production and supply of rum to us, at market terms, for an initial period of 10 years (subject to subsequent renewal periods).
In connection with the acquisitions, we recognized transaction expenses of $55 during fiscal 2023. The transaction expenses largely reflect payments made to terminate certain distribution contracts related to the acquired brands.
v3.25.1
Gain on Business Divestitures
12 Months Ended
Apr. 30, 2025
Discontinued Operations and Disposal Groups [Abstract]  
Gain on Business Divestitures Gain on Business Divestitures
On November 1, 2023, we sold the Finlandia vodka business to Coca-Cola HBC AG for $196 in cash. As a result of the sale, we recognized a pre-tax gain of $92 during fiscal 2024.
On April 30, 2024, we sold the Sonoma-Cutrer wine business to The Duckhorn Portfolio, Inc. (“Duckhorn”) in exchange for an ownership percentage of 21.4% in Duckhorn (Note 5) and cash of $50. As a result of the sale, we recognized a pre-tax gain of $175 during fiscal 2024.
v3.25.1
Derivative Financial Instruments and Hedging Activities
12 Months Ended
Apr. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments and Hedging Activities Derivative Financial Instruments and Hedging Activities
We are subject to market risks, including the effect of fluctuations in foreign currency exchange rates, commodity prices, and interest rates. We use derivatives to help manage financial exposures that occur in the normal course of business. We formally document the purpose of each derivative contract, which includes linking the contract to the financial exposure it is designed to mitigate. We do not hold or issue derivatives for trading or speculative purposes.
We use currency derivative contracts to limit our exposure to the foreign currency exchange risk that we cannot mitigate internally by using netting strategies. We designate most of these contracts as cash flow hedges of forecasted transactions (expected to occur within three years). We record all changes in the fair value of cash flow hedges in accumulated other comprehensive income (AOCI) until the underlying hedged transaction occurs, when we reclassify that amount into earnings.
Some of our currency derivatives are not designated as hedges because we use them to partially offset the immediate earnings impact of changes in foreign currency exchange rates on existing assets or liabilities. We immediately recognize the change in fair value of these contracts in earnings.
We had outstanding currency derivatives, related primarily to our euro, British pound, and Australian dollar exposures, with notional amounts for all hedged currencies totaling $566 and $463 at April 30, 2024 and 2025, respectively. The maximum term of outstanding derivative contracts was 24 months at both April 30, 2024 and 2025.
We also use foreign currency-denominated debt to help manage our foreign currency exchange risk. We designate a portion of those debt instruments as net investment hedges, which are intended to mitigate foreign currency exposure related to non-U.S. dollar net investments in certain foreign subsidiaries. Any change in value of the designated portion of the hedging instruments is recorded in AOCI, offsetting the foreign currency translation adjustment of the related net investments that is also recorded in AOCI. The amount of foreign currency-denominated debt designated as net investment hedges was $497 and $531 as of April 30, 2024 and 2025, respectively.
At inception, we expect each financial instrument designated as a hedge to be highly effective in offsetting the financial exposure it is designed to mitigate, and we assess hedge effectiveness continually. If we determine that any financial instruments designated as hedges are no longer highly effective, we discontinue hedge accounting for those instruments.
We use forward purchase contracts with suppliers to protect against corn price volatility. We expect to take physical delivery of the corn underlying each contract and use it for production over a reasonable period of time. Accordingly, we account for these contracts as normal purchases rather than as derivative instruments.
During fiscal 2024, we reclassified $26 of gains on net investment hedges from AOCI to earnings in connection with the divestiture of Finlandia.
The following table presents the pre-tax impact that changes in the fair value of our derivative instruments and non-derivative hedging instruments had on AOCI and earnings during each of the last three years:
Classification in Statement of Operations202320242025
Currency derivatives designated as cash flow hedges:
Net gain (loss) recognized in AOCIn/a$$11 $(9)
Net gain (loss) reclassified from AOCI into earningsSales37 12 10 
Interest rate derivatives designated as cash flow hedges:
Net gain (loss) recognized in AOCIn/a(1)— — 
Currency derivatives not designated as hedging instruments:
Net gain (loss) recognized in earningsSales(1)— 
Net gain (loss) recognized in earningsOther income (expense), net16 (4)
Foreign currency-denominated debt designated as net investment hedge:
Net gain (loss) recognized in AOCIn/a(32)
Net gain (loss) reclassified from AOCI to earningsGain on business divestitures— 26 — 
Total amounts presented in the accompanying consolidated statements of operations for line items affected by the net gains (losses) shown above:
Sales5,372 5,328 5,056 
Gain on business divestitures
— 267 — 
Other income (expense), net(119)(24)52 
We expect to reclassify $8 of deferred net losses on cash flow hedges recorded in AOCI as of April 30, 2025, to earnings during fiscal 2026. This reclassification would offset the anticipated earnings impact of the underlying hedged exposures. The actual amounts that we ultimately reclassify to earnings will depend on the exchange rates in effect when the underlying hedged transactions occur.
The following table presents the fair values of our derivative instruments as of April 30, 2024 and 2025:
Balance Sheet ClassificationDerivative AssetsDerivative Liabilities
April 30, 2024
Designated as cash flow hedges:
Currency derivativesOther current assets$11 $(2)
Currency derivativesOther assets(1)
Not designated as hedges:
Currency derivativesAccrued expenses— (1)
April 30, 2025
Designated as cash flow hedges:
Currency derivativesAccrued expenses(11)
Currency derivativesOther liabilities— (3)
Not designated as hedges:
Currency derivativesOther current assets— 
The fair values reflected in the above table are presented on a gross basis. However, as discussed further below, the fair values of those instruments subject to net settlement agreements are presented on a net basis in our balance sheets.
In our statements of cash flows, we classify cash flows related to cash flow hedges in the same category as the cash flows from the hedged items.
Credit risk. We are exposed to credit-related losses if the counterparties to our derivative contracts default. This credit risk is limited to the fair value of the contracts. To manage this risk, we contract only with major financial institutions that have earned investment-grade credit ratings and with whom we have standard International Swaps and Derivatives Association (ISDA) agreements that allow for net settlement of the derivative contracts. Also, we have established counterparty credit guidelines that we monitor regularly. Based on our most recent assessment, we consider our counterparty credit risk to be low.
Our derivative instruments require us to maintain a specific level of creditworthiness, which we have maintained. If our creditworthiness were to fall below that level, then the counterparties to our derivative instruments could request immediate payment or collateralization for derivative instruments in net liability positions. The aggregate fair value of all derivatives with creditworthiness requirements that were in a net liability position was $1 and $12 at April 30, 2024 and 2025, respectively.
Offsetting. As noted above, our derivative contracts are governed by ISDA agreements that allow for net settlement of derivative contracts with the same counterparty. It is our policy to present the fair values of current derivatives (that is, those with a remaining term of 12 months or less) with the same counterparty on a net basis in our balance sheets. Similarly, we present the fair values of noncurrent derivatives with the same counterparty on a net basis. We do not net current derivatives with noncurrent derivatives in our balance sheets.
The following table summarizes the gross and net amounts of our derivative contracts:
Gross Amounts of Recognized Assets (Liabilities)
Gross Amounts Offset in
Balance Sheet
Net Amounts Presented in Balance Sheet
Gross Amounts Not Offset in Balance Sheet
Net Amounts
April 30, 2024
Derivative assets$12 $(3)$$— $
Derivative liabilities(4)(1)— (1)
April 30, 2025
Derivative assets(2)— 
Derivative liabilities(14)(12)— (12)
No cash collateral was received or pledged related to our derivative contracts as of April 30, 2024 or 2025.
v3.25.1
Fair Value Measurements
12 Months Ended
Apr. 30, 2025
Fair Value Disclosures [Abstract]  
Fair Value Measurements air Value Measurements
The following table summarizes the assets and liabilities measured or disclosed at fair value on a recurring basis:
 20242025
April 30,Carrying
Amount
Fair
Value
Carrying
Amount
Fair
Value
Assets:
Cash and cash equivalents$446 $446 $444 $444 
Currency derivatives
Liabilities:
Currency derivatives12 12 
Contingent consideration
69 69 31 31 
Short-term borrowings428 428 312 312 
Long-term debt (including current portion)2,672 2,468 2,421 2,255 
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. We categorize the fair values of assets and liabilities into three levels based on the assumptions (inputs) used to determine those values. Level 1 provides the most reliable measure of fair value, while Level 3 generally requires significant management judgment. The three levels are:
Level 1 Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2 Observable inputs other than those included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in inactive markets, or other inputs that are observable or can be derived from or corroborated by observable market data.
Level 3 Unobservable inputs supported by little or no market activity.
We determine the fair values of our currency derivatives (forward contracts) using standard valuation models. The significant inputs used in these models, which are readily available in public markets or can be derived from observable market transactions, include the applicable spot exchange rates, forward exchange rates, and interest rates. These fair value measurements are categorized as Level 2 within the valuation hierarchy.
We determine the fair value of long-term debt primarily based on the prices at which identical or similar debt has recently traded in the market and also considering the overall market conditions on the date of valuation. These fair value measurements are categorized as Level 2 within the valuation hierarchy.
The fair values of cash, cash equivalents, and short-term borrowings approximate the carrying amounts due to the short maturities of these instruments.
We determine the fair value of our contingent consideration liability using a Monte Carlo simulation model, which requires the use of Level 3 inputs, such as projected future net sales, discount rates, and volatility rates. Changes in any of these Level 3 inputs could result in material changes to the fair value of the contingent consideration and could materially impact the amount of non-cash expense (or income) recorded each reporting period.
The following table shows the changes in our contingent consideration liability:
Balance as of April 30, 2023
$63 
Purchase accounting adjustment
(1)
Change in fair value1
Foreign currency translation adjustment(2)
Balance as of April 30, 2024
69 
Change in fair value1
(43)
Foreign currency translation adjustment
Balance as of April 30, 2025
$31 
1Classified as “other expense (income), net” in the accompanying consolidated statement of operations.
The decrease in the fair value of our contingent consideration liability in fiscal 2025 was primarily driven by lower net sales projections for Gin Mare due to the more challenging macroeconomic environment in Europe. See Note 14 for additional information about the contingent consideration liability.
We measure some assets and liabilities at fair value on a nonrecurring basis. That is, we do not measure them at fair value on an ongoing basis, but we do adjust them to fair value in some circumstances (for example, when we determine that an asset is impaired). During the third quarter of fiscal 2023, we recognized a non-cash impairment charge of $96 related to the Finlandia brand name, which was divested on November 1, 2023. Additionally, during the fourth quarter of fiscal 2025, as a result of our annual impairment analysis performed as of the first day of our fourth fiscal quarter, we recognized a non-cash impairment charge of $47 related to the Gin Mare brand name (Note 4). The impairment charges were based on the estimated fair value of each brand name, which we determined using the relief-from-royalty method. The fair value measurements determined using this method are categorized as Level 3 within the valuation hierarchy. No other material nonrecurring fair value measurements were required during the periods presented in these financial statements.
v3.25.1
Leases
12 Months Ended
Apr. 30, 2025
Leases [Abstract]  
Leases Leases
We enter into lease arrangements, which we use primarily for office space, vehicles, and land. Substantially all of our leases are operating leases. Our finance leases are not material.
We record lease liabilities and right-of-use (ROU) assets on our balance sheet for leases with terms exceeding 12 months. We do not record lease liabilities or ROU assets for short-term leases. The amounts recorded for lease liabilities and ROU assets are based on the estimated present value, as of the lease commencement date, of the future payments to be made over the lease term. We calculate the present value using our incremental borrowing rate that corresponds to the term of the lease. We include the effect of an option to renew or terminate a lease in the lease term when it is reasonably certain that we will exercise the option.
Some of our leases contain non-lease components (e.g., maintenance or other services) in addition to lease components. We have elected the practical expedient not to separate the non-lease components from the lease components.
The following table shows information about our leases as of the end of the last two years:
Balance Sheet ClassificationApril 30,
2024
April 30,
2025
Right-of-use assetsOther assets$96 $101 
Lease liabilities:
CurrentAccounts payable and accrued expenses$24 $26 
Non-currentOther liabilities73 78 
Total$97 $104 
Weighted-average discount rate4.2%4.5%
Weighted-average remaining term5.1 years4.8 years
The following table shows information about the effects of leases during each of the last three years:
202320242025
Total lease cost1
$38 $51 $45 
Cash paid for amounts included in the measurement of lease liabilities2
25 29 30 
Right-of-use assets obtained in exchange for new lease liabilities29 38 33 
1Consists primarily of operating lease cost. Other components of lease cost were not material.
2Classified within operating activities in the accompanying consolidated statements of cash flows.

The following table includes a maturity analysis of future (undiscounted) lease payments and a reconciliation of those payments to the lease liabilities recorded on our balance sheet as of April 30, 2025:
April 30,
2025
2026
$30 
2027
27 
2028
20 
2029
16 
2030
12 
Thereafter10 
Total lease payments115 
Less: Present value discount(11)
Lease liabilities$104 
v3.25.1
Other Comprehensive Income
12 Months Ended
Apr. 30, 2025
Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Other Comprehensive Income Other Comprehensive Income
The following table presents the components of net other comprehensive income (loss) during each of the last three years:
Pre-TaxTaxNet
Year Ended April 30, 2023
Currency translation adjustments:
Net gain (loss) on currency translation$135 $— $135 
Reclassification to earnings— — — 
Other comprehensive income (loss), net135 — 135 
Cash flow hedge adjustments:
Net gain (loss) on hedging instruments(1)
Reclassification to earnings1
(37)(29)
Other comprehensive income (loss), net(34)(27)
Postretirement benefits adjustments:
Net actuarial gain (loss) and prior service cost(26)(20)
Reclassification to earnings2
38 (9)29 
Other comprehensive income (loss), net12 (3)
Total other comprehensive income (loss), net$113 $$117 
Year Ended April 30, 2024
Currency translation adjustments:
Net gain (loss) on currency translation$(16)$(1)$(17)
Reclassification to earnings3
10 
Other comprehensive income (loss), net(12)(7)
Cash flow hedge adjustments:
Net gain (loss) on hedging instruments11 (2)
Reclassification to earnings1
(12)(9)
Other comprehensive income (loss), net(1)— 
Postretirement benefits adjustments:
Net actuarial gain (loss) and prior service cost22 (5)17 
Reclassification to earnings2
(2)
Other comprehensive income (loss), net28 (7)21 
Total other comprehensive income (loss), net$15 $(1)$14 
Year Ended April 30, 2025
Currency translation adjustments:
Net gain (loss) on currency translation$$10 $19 
Reclassification to earnings— — — 
Other comprehensive income (loss), net10 19 
Cash flow hedge adjustments:
Net gain (loss) on hedging instruments(9)(7)
Reclassification to earnings1
(10)(8)
Other comprehensive income (loss), net(19)(15)
Postretirement benefits adjustments:
Net actuarial gain (loss) and prior service cost(8)(5)
Reclassification to earnings2
— 
Other comprehensive income (loss), net(6)(3)
Total other comprehensive income (loss), net$(16)$17 $
1Pre-tax amount is classified as sales in the accompanying consolidated statements of operations.
2Pre-tax amount is classified as non-operating postretirement expense in the accompanying consolidated statements of operations.
3Pre-tax amount is classified in gain on business divestitures in the accompanying consolidated statements of operations.
v3.25.1
Segment and Other Information
12 Months Ended
Apr. 30, 2025
Segment Reporting [Abstract]  
Segment and Other Information Segment and Other Information
Our business constitutes a single operating segment, which derives its revenues predominantly from global sales of beverage alcohol consumer products.
Our Chief Executive Officer is our chief operating decision maker, who manages business operations, evaluates performance, and allocates resources based on segment metrics such as net sales, gross profit, operating income, and net income. Significant segment expenses include cost of sales, advertising expenses, and selling, general, and administrative expenses. Other segment items include (when applicable): restructuring and other charges; gain on business divestitures; other expense (income), net; non-operating postretirement expense; interest income; interest expense; equity method investment income and gain on sale; and income taxes. The amount of each of these segment measures is the same as the consolidated amount presented in the accompanying consolidated statements of operations.
The segment’s assets, expenditures for additions to long-lived assets, and depreciation and amortization are the same as the consolidated amounts presented in the accompanying consolidated balance sheets and consolidated statements of cash flows.
The following table presents consolidated net sales by country: 
202320242025
United States
$1,968 $1,889 $1,765 
Mexico
244 290 267 
Germany
239 263 253 
Australia
221 204 199 
United Kingdom
207 185 174 
Other1
1,349 1,347 1,317 
Total net sales
$4,228 $4,178 $3,975 
1Includes net sales of (a) branded products to countries not listed above; (b) branded products to global duty-free customers, other travel retail customers, and the U.S. military, regardless of customer location; and (c) used barrels, contract bottling services, and non-branded bulk whiskey, regardless of customer location.

Net sales are attributed to countries based on where customers are located. See Note 10 for additional information about net sales, including net sales by product category.
Our two largest customers accounted for 14% and 12% of consolidated net sales in 2023; 13% and 11% of consolidated net sales in 2024; and 13% and 11% of consolidated net sales in 2025.
The net book value of property, plant, and equipment located outside the United States was $255 and $283 as of April 30, 2024 and 2025, respectively. Other long-lived assets located outside the United States are not significant.
v3.25.1
Assets Held for Sale
12 Months Ended
Apr. 30, 2025
Discontinued Operations and Disposal Groups [Abstract]  
Divestitures Assets Held for Sale
As discussed in Note 6, our Restructuring Initiative included the planned closure of our Louisville-based Brown-Forman Cooperage. In January 2025, we reached an agreement to close that facility and sell the related assets.
In connection with this transaction, we recorded a $2 impairment charge in 2025 to write down the long-lived assets held for sale to their estimated fair value (net of selling costs). We also recorded $3 in charges to adjust the carrying amount of inventories held for sale as part of the transaction. We estimated the fair value based on the expected proceeds from the transaction. The carrying amount of the assets held for sale as of April 30, 2025, was $121, consisting of $33 in property, plant, and equipment, net, and $88 in inventories. The total carrying amount of the assets held for sale is presented as a separate line item in the consolidated balance sheet as of April 30, 2025.
On May 1, 2025, we completed the sale of the facility and related assets, resulting in an immaterial pre-tax impact on our consolidated statement of operations in fiscal 2026.
v3.25.1
Schedule II - Valuation and Qualifying Accounts
12 Months Ended
Apr. 30, 2025
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II - Valuation and Qualifying Accounts
Schedule II – Valuation and Qualifying Accounts
For the Years Ended April 30, 2023, 2024, and 2025
(Expressed in millions)
 
Col. ACol. BCol. C(1)Col. C(2)Col. DCol. E
DescriptionBalance at
Beginning
of Period
Additions
Charged to
Costs and
Expenses
Additions
Charged to
Other
Accounts
DeductionsBalance
at End
of Period
2023
Allowance for doubtful accounts$13 $— $— $
(1)
$
Deferred tax valuation allowance$27 $$— $17 $14 
2024
Allowance for doubtful accounts$$$— $— $
Deferred tax valuation allowance$14 $$$$16 
2025
Allowance for doubtful accounts$$$— $
(1)
$
Deferred tax valuation allowance$16 $$14 $$35 
 
(1)Doubtful accounts written off, net of recoveries.
v3.25.1
Pay vs Performance Disclosure - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Pay vs Performance Disclosure      
Net income $ 869 $ 1,024 $ 783
v3.25.1
Insider Trading Arrangements
3 Months Ended
Apr. 30, 2025
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Lawson E. Whiting [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Name & TitleActionCharacter of Trading ArrangementDate
Duration of Trading Arrangement1
Aggregate Number of Securities to be Sold Pursuant to Trading Arrangement
Lawson E. Whiting

President and Chief Executive Officer
AdoptionRule 10b5-1 trading arrangement3/31/20253/31/2026
Up to 70,921 shares of the Company’s Class A and/or Class B common stock
1Trading arrangement terminates upon the earlier of (a) the completion of all sales under the trading arrangement and (b) the date listed in the table above.
Name Lawson E. Whiting
Title President and Chief Executive Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date 3/31/2025
Expiration Date 3/31/2026
Arrangement Duration 365 days
Aggregate Available 70,921
v3.25.1
Insider Trading Policies and Procedures
12 Months Ended
Apr. 30, 2025
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.1
Cybersecurity Risk Management and Strategy Disclosure
12 Months Ended
Apr. 30, 2025
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Our Chief Information Security Officer (CISO) leads our Global Information Security team, reports to the Chief Information Officer (CIO), and meets regularly with other members of senior management. Our CISO holds advanced degrees in Computer Science and Business Administration, in addition to relevant IT and cybersecurity certifications from organizations such as the EC Council, ISACA, and CSA. She has served in various IT roles for over 20 years, including leading the IT Security function.
Our Global Information Security team is responsible for the information security strategy, policy, security engineering, operations, and cyberthreat detection and response. Our Global Information Security team, which includes a security operations center, seeks to protect the company against reasonably foreseeable cyberthreats and risks. The cybersecurity team members have the qualifications and certifications required for their roles. In addition, they have relevant industry experience in selecting, deploying, and operating cybersecurity technologies, initiatives, and processes globally. In order to stay ahead of potential threats and enhance our overall security posture, we rely on threat intelligence as well as other information obtained from governmental, public, or private sources, including external consultants that we engage.
We have made significant investments in people, processes, and technology to protect the confidentiality, integrity, and availability of our IT systems. As part of that effort, we utilize the National Institute of Standards and Technology Cybersecurity Framework as a guide for our security controls. We are continuing to advance towards an architecture based on “Zero-Trust” principles, where we continuously validate the identity and security posture of every user, device, application, or network component trying to leverage our IT resources. We temper this architecture with a business-risk-based approach that ensures we protect our digital assets while aligning our security measures with our overall organizational goals and priorities. In addition, our employees undergo annual security awareness training to improve their understanding of cybersecurity threats, and their ability to identify and escalate potential threats.
In the event of an incident, we leverage a multi-layered set of plans that include Endpoint Detection and Response software, Security Information and Event Management tools for detection, a Cybersecurity Incident Response Plan, and a Disaster Recovery Response Plan for recovery. The recovery plans outline the steps to be followed from incident detection to mitigation, recovery, and notification, including notifying designated functional leadership teams, the Disclosure Committee, the General Counsel, other senior leadership, and the Board of Directors, as appropriate. These designated leaders assess various factors, including operational, financial, legal, regulatory, and reputational impacts on the Company to determine the materiality of the incident and the appropriate response.
We have established a tiered risk management strategy that helps us to evaluate our ability to protect assets (data and systems) by identifying, assessing, and prioritizing associated risk through, among other tools, the use of a non-affiliated third-party assessor, audits by our internal audit team, tabletop exercises, penetration and vulnerability tests, and simulations. We report the results of these assessments to the Audit Committee of the Board of Directors.
We rely on third-party service providers to deliver our products and services to our customers, including many of our technology initiatives. A cybersecurity incident at a supplier, subcontractor, or joint venture partner could materially adversely impact us. We evaluate third-party providers from a cybersecurity risk perspective, which may include an assessment of that service provider’s cybersecurity posture through a questionnaire, and include security and privacy addenda to our contracts where applicable. However, we rely on the third parties we use to implement security programs commensurate with their risk, and we cannot ensure in all circumstances that their efforts will be successful.
Our systems periodically experience directed attacks intended to lead to interruptions and delays in our service and operations as well as loss, misuse, or theft of personal information (of third parties, employees and their beneficiaries, and customers) and other data. These incidents have not had a material impact on our services, systems, or business. However, despite our capabilities, processes, and other security measures we employ, we may not be aware of all vulnerabilities or might not accurately assess the risk of an incident. Additional information on cybersecurity risks we face can be found in Item 1A. Risk Factors, which should be read in conjunction with the foregoing information.
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block] We have established a tiered risk management strategy that helps us to evaluate our ability to protect assets (data and systems) by identifying, assessing, and prioritizing associated risk through, among other tools, the use of a non-affiliated third-party assessor, audits by our internal audit team, tabletop exercises, penetration and vulnerability tests, and simulations.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block] The Board of Directors oversees management’s processes for identifying and mitigating risks, including cybersecurity risks, to help align our risk exposure with our strategic objectives. The Board of Directors has delegated oversight of risks related to cybersecurity to the Audit Committee.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] The Audit Committee oversees our cybersecurity posture to assess key strategic, operational, and compliance risks.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Our CIO and CISO update the Audit Committee quarterly regarding cyber risks, the threat landscape, reports on our security roadmap, risk mitigation and governance, and any cybersecurity incidents.
Cybersecurity Risk Role of Management [Text Block]
Our Chief Information Security Officer (CISO) leads our Global Information Security team, reports to the Chief Information Officer (CIO), and meets regularly with other members of senior management. Our CISO holds advanced degrees in Computer Science and Business Administration, in addition to relevant IT and cybersecurity certifications from organizations such as the EC Council, ISACA, and CSA. She has served in various IT roles for over 20 years, including leading the IT Security function.
Our Global Information Security team is responsible for the information security strategy, policy, security engineering, operations, and cyberthreat detection and response. Our Global Information Security team, which includes a security operations center, seeks to protect the company against reasonably foreseeable cyberthreats and risks. The cybersecurity team members have the qualifications and certifications required for their roles. In addition, they have relevant industry experience in selecting, deploying, and operating cybersecurity technologies, initiatives, and processes globally. In order to stay ahead of potential threats and enhance our overall security posture, we rely on threat intelligence as well as other information obtained from governmental, public, or private sources, including external consultants that we engage.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Our Chief Information Security Officer (CISO) leads our Global Information Security team, reports to the Chief Information Officer (CIO), and meets regularly with other members of senior management.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Our CISO holds advanced degrees in Computer Science and Business Administration, in addition to relevant IT and cybersecurity certifications from organizations such as the EC Council, ISACA, and CSA. She has served in various IT roles for over 20 years, including leading the IT Security function.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] The Company’s Information Technology, Enterprise Security, Internal Audit, as well as the Legal and Privacy teams work closely to identify issues and incidents in a timely manner and report them to senior leadership, the Board of Directors, and regulatory bodies, as appropriate.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.25.1
Accounting Policies (Policies)
12 Months Ended
Apr. 30, 2025
Accounting Policies [Abstract]  
Principles of consolidation
Principles of consolidation. Our consolidated financial statements include the accounts of all subsidiaries in which we have a controlling financial interest. We use the equity method to account for investments in entities that we do not control but over whose operating and financial policies we have the ability to exercise significant influence. We eliminate all intercompany transactions.
Estimates
Estimates. To prepare financial statements that conform with GAAP, our management must make informed estimates that affect how we report revenues, expenses, assets, and liabilities, including contingent assets and liabilities. Actual results could differ from these estimates.
Cash equivalents
Cash equivalents. Cash equivalents include bank demand deposits and all highly liquid investments with original maturities of three months or less.
Accounts receivable
Accounts receivable. Accounts receivable are recorded net of an allowance for expected credit losses (allowance for doubtful accounts). We determine the allowance using information such as customer credit history and financial condition, historical loss experience, and macroeconomic factors. We write off account balances against the allowance when we have exhausted our collection efforts. The allowance for doubtful accounts was $8 and $7 at April 30, 2024 and 2025, respectively.
Inventories
Inventories. Inventories are valued at the lower of cost or net realizable value. Approximately 50% of our consolidated inventories are valued using the last-in, first-out (LIFO) cost method, which we use for the majority of our U.S. inventories. We value the remainder of our inventories primarily using the first-in, first-out (FIFO) cost method. FIFO cost approximates current replacement cost. If we had used the FIFO method for all inventories, they would have been $512 and $600 higher than reported at April 30, 2024 and 2025, respectively.
Because we age most of our whiskeys in barrels for three years or more, we bottle and sell only a portion of our whiskey inventory each year. Following industry practice, we classify all barreled whiskey as a current asset. We include warehousing, insurance, ad valorem taxes, and other carrying charges applicable to barreled whiskey in inventory costs.
We classify agave inventories, bulk tequila, barreled rum, and liquid in bottling tanks as work in process.
Property, plant, and equipment
Property, plant, and equipment. We state property, plant, and equipment at cost less accumulated depreciation. We calculate depreciation on a straight-line basis using our estimates of useful life, which are 20–40 years for buildings and improvements; 3–10 years for machinery, equipment, vehicles, furniture, and fixtures; and 3–7 years for capitalized software.
We assess our property, plant, and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of those assets may not be recoverable. When we do not expect to recover the carrying value of an asset (or asset group) through undiscounted future cash flows, we write it down to its estimated fair value. We determine fair value using discounted estimated future cash flows, considering market values for similar assets when available.
When we retire or dispose of property, plant, and equipment, we remove its cost and accumulated depreciation from our balance sheet and reflect any gain or loss in operating income. We expense the costs of repairing and maintaining our property, plant, and equipment as we incur them.
Goodwill and other intangible assets
Goodwill and other intangible assets. When we acquire a business, we first allocate the purchase price to identifiable assets and liabilities, including intangible brand names and trademarks (“brand names”), based on estimated fair value. We then record any remaining purchase price as goodwill. We do not amortize goodwill or other intangible assets with indefinite lives. We consider all of our brand names to have indefinite lives.
We assess our goodwill and other indefinite-lived intangible assets for impairment at least annually, or more frequently if circumstances indicate the carrying amount may be impaired. Goodwill is impaired when the carrying amount of the related reporting unit exceeds its estimated fair value, in which case we write down the goodwill by the amount of the excess (limited to the carrying amount of the goodwill). We estimate the reporting unit’s fair value using discounted estimated future cash flows or market information. Similarly, a brand name is impaired when its carrying amount exceeds its estimated fair value, in which case we write down the brand name to its estimated fair value. We estimate the fair value of a brand name using the
relief-from-royalty method. We also consider market values for similar assets when available. Considerable management judgment is necessary to estimate fair value, including the selection of assumptions about future cash flows, net sales, discount rates, and royalty rates.
We have the option, before quantifying the fair value of a reporting unit or brand name, to evaluate qualitative factors to assess whether it is more likely than not that our goodwill or brand names are impaired. If we determine that is not the case, then we are not required to quantify the fair value. That assessment also takes considerable management judgment.
Revenue recognition
Revenue recognition. Our net sales predominantly reflect global sales of beverage alcohol consumer products. We sell these products under contracts with different types of customers, depending on the market. The customer is most often a distributor, wholesaler, or retailer.
Each contract typically includes a single performance obligation to transfer control of the products to the customer. Depending on the contract, control is transferred when the products are either shipped or delivered to the customer, at which point we recognize the transaction price for those products as net sales. The transaction price recognized at that point reflects our estimate of the consideration to be received in exchange for the products. The actual amount may ultimately differ due to the effect of various customer incentives and trade promotion activities. In making our estimates, we consider our historical experience and current expectations, as applicable. Subsequent adjustments recognized for changes in estimated transaction prices are typically not material.
Net sales exclude taxes we collect from customers that are imposed by various governments on our sales, and are reduced by payments to customers unless made in exchange for distinct goods or services with fair values approximating the payments. Net sales include any amounts we bill customers for shipping and handling activities related to the products. We recognize the cost of those activities in cost of sales during the same period in which we recognize the related net sales. Sales returns, which are permitted only in limited situations, are not material. Customer payment terms generally range from 30 to 90 days. There are no significant amounts of contract assets or liabilities.
Cost of sales
Cost of sales. Cost of sales includes the costs of receiving, producing, inspecting, warehousing, insuring, and shipping goods sold during the period.
Advertising costs
Advertising costs. We expense the production costs of advertising when the advertisements first take place. We expense all other advertising costs during the year in which the costs are incurred.
Selling, general, and administrative expenses
Selling, general, and administrative expenses. Selling, general, and administrative expenses include the costs associated with our sales force, administrative staff and facilities, and other expenses related to our non-manufacturing functions.
Stock-based compensation
Stock-based compensation. We use stock-based awards as part of our incentive compensation for eligible employees and directors. We recognize the grant-date fair value of an award as compensation expense on a straight-line basis over the requisite service period, which typically corresponds to the vesting period for the award. Upon forfeiture of an award prior to vesting, we reverse any previously recognized compensation expense related to that award. We classify stock-based compensation expense within selling, general, and administrative expenses.
As we recognize compensation expense for a stock-based award, we concurrently recognize a related deferred tax asset. The subsequent vesting or exercise of the award will generally result in an actual tax benefit that differs from the deferred tax asset that had been recorded. The excess (deficiency) of the actual tax benefit over (under) the previously recorded tax asset is recognized as income tax benefit (expense) on the date of vesting or exercise.
Income taxes
Income taxes. We base our annual provision for income taxes on the pre-tax income reflected in our consolidated statement of operations. We establish deferred tax liabilities or assets for temporary differences between GAAP and tax reporting bases and later adjust them to reflect changes in tax rates expected to be in effect when the temporary differences reverse. We record a valuation allowance as necessary to reduce a deferred tax asset to the amount that we believe is more likely than not to be realized. Certain income earned by foreign subsidiaries is subject to Global Intangible Low-Taxed Income (GILTI), a U.S. tax on foreign earnings. We treat the tax effect of GILTI as a current period tax expense when incurred. We do not provide deferred income taxes on undistributed earnings of foreign subsidiaries that we expect to indefinitely reinvest. We record a deferred tax charge in prepaid taxes for the difference between GAAP and tax reporting bases with respect to the elimination of intercompany profit in ending inventory.
We assess our uncertain income tax positions in two steps. First, we evaluate whether the tax position will, more likely than not, based on its technical merits, be sustained upon examination, including resolution of any related appeals or litigation. For a tax position that does not meet this first criterion, we recognize no tax benefit. For a tax position that does meet the first criterion, we recognize a tax benefit in an amount equal to the largest amount of benefit that we believe has more than a 50%
likelihood of being realized upon ultimate resolution. We record interest and penalties on uncertain tax positions as income tax expense.
Foreign currency transactions and translation
Foreign currency transactions and translation. We report all gains and losses from foreign currency transactions (those denominated in a currency other than the entity’s functional currency) in current income. The U.S. dollar is the functional currency for most of our consolidated entities. The local currency is the functional currency for some of our consolidated foreign entities. We translate the financial statements of those foreign entities into U.S. dollars, using the exchange rate in effect at the balance sheet date to translate assets and liabilities, and using the average exchange rate for the reporting period to translate income and expenses. We record the resulting translation adjustments in other comprehensive income (loss).
Reclassifications
Reclassifications: Certain prior year amounts have been reclassified to conform with the current year’s presentation.
Accounting standards not yet adopted
Recently adopted accounting standard. In November 2023, the Financial Accounting Standards Board (FASB) issued an updated accounting standard requiring additional disclosures about significant segment expenses and other segment items. We adopted the updated standard as of April 30, 2025 (Note 20). Adoption had no material impact on our consolidated financial statements.
Accounting standards not yet adopted. In December 2023, the FASB issued an updated accounting standard requiring additional disclosures about income taxes, primarily related to the rate reconciliation and information about income taxes paid. We are required to adopt the new guidance beginning in fiscal 2026. The update can be applied either prospectively or retrospectively.
In November 2024, the FASB issued an updated accounting standard requiring disaggregation, in the notes to the financial statements, of expense line items in the income statement that include certain categories of expenses. We are required to adopt the updated standard for annual disclosures beginning in fiscal 2028, and for interim disclosures in fiscal 2029, with earlier adoption permitted. The update can be applied either prospectively or retrospectively.
We are currently evaluating the impact that adopting these accounting standards updates will have on our disclosures.
v3.25.1
Derivative Financial Instruments and Hedging Activities (Policies)
12 Months Ended
Apr. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Classification of Cash Flows Related to Cash Flow Hedges [Policy Text Block]
In our statements of cash flows, we classify cash flows related to cash flow hedges in the same category as the cash flows from the hedged items.
Derivatives, Offsetting Fair Value Amounts, Policy [Policy Text Block]
Offsetting. As noted above, our derivative contracts are governed by ISDA agreements that allow for net settlement of derivative contracts with the same counterparty. It is our policy to present the fair values of current derivatives (that is, those with a remaining term of 12 months or less) with the same counterparty on a net basis in our balance sheets. Similarly, we present the fair values of noncurrent derivatives with the same counterparty on a net basis. We do not net current derivatives with noncurrent derivatives in our balance sheets.
v3.25.1
Leases (Policies)
12 Months Ended
Apr. 30, 2025
Leases [Abstract]  
Lessee, Leases [Policy Text Block]
We record lease liabilities and right-of-use (ROU) assets on our balance sheet for leases with terms exceeding 12 months. We do not record lease liabilities or ROU assets for short-term leases. The amounts recorded for lease liabilities and ROU assets are based on the estimated present value, as of the lease commencement date, of the future payments to be made over the lease term. We calculate the present value using our incremental borrowing rate that corresponds to the term of the lease. We include the effect of an option to renew or terminate a lease in the lease term when it is reasonably certain that we will exercise the option.
Some of our leases contain non-lease components (e.g., maintenance or other services) in addition to lease components. We have elected the practical expedient not to separate the non-lease components from the lease components.
v3.25.1
Balance Sheet Information (Tables)
12 Months Ended
Apr. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Supplemental information on year end balance sheets
Supplemental information on our year-end balance sheets is as follows:
April 30,20242025
Property, plant, and equipment:
Land$49 49
Buildings782 841
Equipment928 869
Construction in process181 180
1,940 1,939 
Less accumulated depreciation866 844
$1,074 $1,095 
Accounts payable and accrued expenses:
Accounts payable, trade$267 $243 
Accrued expenses:
Advertising, promotion, and discounts200 197 
Compensation and commissions105 86 
Excise and other non-income taxes67 67 
Other154 148 
526 498 
$793 $741 
Other liabilities:
Contingent consideration
$69 $31 
Other174 156 
$243 $187 
April 30,20242025
Accumulated other comprehensive income (loss), net of tax:
Currency translation adjustments$(111)$(92)
Cash flow hedge adjustments10 (5)
Postretirement benefits adjustments(120)(123)
$(221)$(220)
v3.25.1
Earnings Per Share (Tables)
12 Months Ended
Apr. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
The following table presents information concerning basic and diluted earnings per share: 
202320242025
Net income available to common stockholders$783 $1,024 $869 
Share data (in thousands):
Basic average common shares outstanding479,155 476,394 472,655 
Dilutive effect of stock-based awards1,310 826 295 
Diluted average common shares outstanding480,465 477,220 472,950 
Basic earnings per share$1.63 $2.15 $1.84 
Diluted earnings per share$1.63 $2.14 $1.84 
v3.25.1
Goodwill and Other Intangible Assets (Tables)
12 Months Ended
Apr. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets and Goodwill [Table Text Block]
The following table shows the changes in goodwill (which include no accumulated impairment losses) and other intangible assets over the past two years: 
GoodwillOther Intangible Assets
Balance as of April 30, 2023
$1,457 $1,164 
Purchase accounting adjustments
40 (53)
Business divestitures
(28)(89)
Foreign currency translation adjustment(14)(25)
Impairment— (7)
Balance as of April 30, 2024
1,455 990 
Foreign currency translation adjustment50 38 
Impairment— (47)
Balance as of April 30, 2025
$1,505 $981 
v3.25.1
Restructuring and Other Charges (Tables)
12 Months Ended
Apr. 30, 2025
Restructuring and Related Activities [Abstract]  
Restructuring and Related Costs [Table Text Block]
The following table summarizes the restructuring and other charges recognized in fiscal 2025:
Restructuring charges:
   Severance and other employee-related costs
$24 
   Other restructuring charges1
22 
Restructuring charges46 
Other charges2
14 
Total restructuring and other charges$60 
1Primarily represents one-time costs related to the cooperage facility closure, consulting services, and other miscellaneous exit costs.
2Represents $12 in costs associated with a special one-time early retirement benefit to qualifying U.S. employees and $2 in impairment charges on certain cooperage facility assets held for sale.
Schedule of Restructuring Reserve by Type of Cost {Table Text Block]
The following table summarizes the activity in our accrued restructuring costs:
Severance and Other Employee-Related CostsOther Restructuring ChargesTotal
Balance at April 30, 2024$— $— $— 
Costs incurred and charged to expense24 22 46 
Costs paid or otherwise settled(11)(16)(27)
Balance at April 30, 2025$13 $$19 
v3.25.1
Debt and Credit Facilities (Tables)
12 Months Ended
Apr. 30, 2025
Debt Disclosure [Abstract]  
Schedule of long-term debt
Our long-term debt (net of unamortized discounts and issuance costs) consisted of:
April 30,20242025
3.50% senior notes, $300 principal amount, due April 15, 2025
$300 $— 
1.20% senior notes, €300 principal amount, due July 7, 2026
321 342 
2.60% senior notes, £300 principal amount, due July 7, 2028
375 401 
4.75% senior notes, $650 principal amount, due April 15, 2033
643 644 
4.00% senior notes, $300 principal amount, due April 15, 2038
295 296 
3.75% senior notes, $250 principal amount, due January 15, 2043
248 248 
4.50% senior notes, $500 principal amount, due July 15, 2045
490 490 
2,672 2,421 
Less current portion300 — 
$2,372 $2,421 
Schedule of short-term debt
April 30,20242025
Commercial paper (par amount)
$429$313
Average interest rate5.49%4.64%
Average remaining days to maturity1212
v3.25.1
Common Stock (Tables)
12 Months Ended
Apr. 30, 2025
Class of Stock [Line Items]  
Schedule of Common Stock Outstanding Roll Forward [Table Text Block]
The following table shows the change in outstanding common shares during each of the last three years:
(Shares in thousands)Class AClass BTotal
Balance at April 30, 2022
169,175 309,845 479,020 
Stock issued under compensation plans65 231 296 
Balance at April 30, 2023
169,240 310,076 479,316 
Acquisition of treasury stock(176)(6,736)(6,912)
Stock issued under compensation plans44 152 196 
Balance at April 30, 2024
169,108 303,492 472,600 
Stock issued under compensation plans21 48 69 
Balance at April 30, 2025
169,129 303,540 472,669 
v3.25.1
Net Sales (Tables)
12 Months Ended
Apr. 30, 2025
Net Sales [Abstract]  
Disaggregation of Revenue [Table Text Block]
The following table shows our net sales by geography:
202320242025
United States
$1,968 $1,889 $1,765 
Developed International1
1,178 1,154 1,090 
Emerging2
824 869 852 
Travel Retail3
170 179 166 
Non-branded and bulk4
88 87 102 
$4,228 $4,178 $3,975 
1Represents net sales of branded products to “advanced economies” as defined by the International Monetary Fund (IMF), excluding the United States. Our top developed international markets are Germany, Australia, the United Kingdom, France, and Canada.
2Represents net sales of branded products to “emerging and developing economies” as defined by the IMF. Our top emerging markets are Mexico, Poland, Brazil, and Türkiye.
3Represents net sales of branded products to global duty-free customers, other travel retail customers, and the U.S. military, regardless of customer location.
4Includes net sales of used barrels, contract bottling services, and non-branded bulk whiskey, regardless of customer location.

The following table shows our net sales by product category:
202320242025
Whiskey1
$2,915 $2,832 $2,828 
Ready-to-Drink2
509 520 491 
Tequila3
320 306 262 
Non-branded and bulk4
88 87 102 
Rest of portfolio5
396 433 292 
$4,228 $4,178 $3,975 
1Includes all whiskey spirits and whiskey-based flavored liqueurs. The brands included in this category are the Jack Daniel’s family of brands (excluding the “Ready-to-Drink” products outlined below), the Woodford Reserve family of brands, the Old Forester family of brands, The Glendronach, Benriach, Glenglassaugh, and Slane Irish Whiskey.
2Includes the Jack Daniel’s ready-to-drink (RTD) and ready-to-pour (RTP) products, New Mix, and other RTD/RTP products.
3Includes el Jimador, the Herradura family of brands, and other tequilas.
4Includes net sales of used barrels, contract bottling services, and non-branded bulk whiskey.
5Includes Korbel California Champagnes and Korbel Brandy (announced the end of the sales, marketing, and distribution relationship effective June 30, 2025), Diplomático, Chambord, Gin Mare, Sonoma-Cutrer (which was divested on April 30, 2024), Finlandia Vodka (which was divested on November 1, 2023), Fords Gin, and other agency brands (brands we do not own, but sell in certain markets).
v3.25.1
Pension and Other Postretirement Benefits (Tables)
12 Months Ended
Apr. 30, 2025
Retirement Benefits [Abstract]  
Change in present value of pension and other postretirement benefit obligation The following table shows how the present value of our projected benefit obligations changed during each of the last two years. 
 Pension BenefitsMedical and Life
Insurance Benefits
 2024202520242025
Obligation at beginning of year$731 $679 $40 $36 
Service cost18 16 — — 
Interest cost34 35 
Net actuarial loss (gain)1
(61)(3)
Plan amendments— — — 
Retiree contributions— — 
Benefits paid(44)(52)(6)(5)
Special termination benefits— — — 
Obligation at end of year$679 $683 $36 $39 
1 The net actuarial loss (gain) during each year was primarily attributable to changes in discount rates.
Expected benefit payments over the next 10 years Expected benefit payments (net of retiree contributions) over the next 10 years are as follows:
Pension BenefitsMedical and Life
Insurance Benefits
2026$105 $
202750 
202851 
202952 
203052 
2031 – 2035260 15 
Fair value of pension plan assets by category, as well as the actual and target allocations
The following table shows the fair value of pension plan assets by category as of the end of the last two years. (Fair value levels are defined in Note 17.)
 Level 1Level 2Level 3Total
April 30, 2024
Equity securities$31 $— $— $31 
Fixed income investments
— 278 — 278 
Limited partnership interest1
— — 
$31 $278 $310 
Investments measured at net asset value:
Commingled trust funds2:
Equity funds118 
Fixed income funds53 
Real estate fund49 
Short-term investments11 
Limited partnership interests3
38 
Net receivable (payable) for pending transactions
(3)
Total$576 
April 30, 2025
Equity securities$25 $— $— $25 
Fixed income investments— 242 — 242 
Limited partnership interest1
— — 
$25 $242 $268 
Investments measured at net asset value:
Commingled trust funds2:
Equity funds115 
Fixed income funds28 
Real estate fund41 
Short-term investments75 
Limited partnership interests3
47 
Net receivable (payable) for pending transactions
Total$576 
1 This limited partnership interest was initially valued at cost and has been adjusted to fair value as determined in good faith by management of the partnership using various factors, and does not meet the requirements for reporting at the net asset value (NAV). The valuation requires significant judgment due to the absence of quoted market prices and the inherent lack of liquidity. This limited partnership has a term expiring in September 2025.
2 Commingled trust fund valuations are based on the NAV of the funds as determined by the fund administrators and reviewed by us. NAV represents the underlying assets owned by the fund, minus liabilities and divided by the number of shares or units outstanding. Generally, for commingled trust funds other than real estate, redemptions are permitted daily with no notice period. The real estate fund is redeemable quarterly with 110 days’ notice.
3 These limited partnership interests were initially valued at cost and have been adjusted using NAV per audited financial statements. Investments are generally not eligible for immediate redemption and have original terms averaging 10 to 13 years, although those periods may be extended.
Change in fair value of pension plan Assets
The following table shows how the total fair value of all pension plan assets changed during each of the last two years. (We do not have assets set aside for postretirement medical or life insurance benefits.) 
 Pension BenefitsMedical and Life
Insurance Benefits
 2024202520242025
Assets at beginning of year$606 $576 $— $— 
Actual return on assets(2)36 — — 
Retiree contributions— — 
Company contributions16 16 
Benefits paid(44)(52)(6)(5)
Assets at end of year$576 $576 $— $— 
Funded status of plans The following table shows the funded status of our plans.
 Pension BenefitsMedical and Life
Insurance Benefits
April 30,2024202520242025
Assets$576 $576 $— $— 
Obligations(679)(683)(36)(39)
Funded status$(103)$(107)$(36)$(39)
Funded status is recorded on the accompanying consolidated balance sheets
The funded status is recorded on the accompanying consolidated balance sheets as follows: 
 
Pension Benefits
Medical and Life
Insurance Benefits
April 30,2024202520242025
Other assets$32 $31 $— $— 
Accounts payable and accrued expenses(8)(9)(3)(4)
Accrued pension and other postretirement benefits(127)(129)(33)(35)
Net liability$(103)$(107)$(36)$(39)
Accumulated other comprehensive income (loss), before tax:
Net actuarial gain (loss)$(166)$(171)$$— 
Prior service credit (cost)(4)(2)
$(170)$(173)$$
Pension plans with accumulated benefit obligation in excess of plan assets
The following table compares our pension plans whose accumulated benefit obligations exceed their assets with our pension plans whose assets exceed their accumulated benefit obligations.
 Accumulated
Benefit Obligation
Plan Assets
April 30,2024202520242025
Plans with accumulated benefit obligation in excess of assets$(124)$(128)$— $— 
Plans with assets in excess of accumulated benefit obligation(487)(507)576 576 
Total$(611)$(635)$576 $576 
Pension plans with projected benefit obligation in excess of plan assets
The following table compares our pension plans whose projected benefit obligations exceed their assets with our pension plans whose assets exceed their projected benefit obligations.
 Projected
Benefit Obligation
Plan Assets
April 30,2024202520242025
Plans with projected benefit obligation in excess of assets$(135)$(138)$— $— 
Plans with assets in excess of projected benefit obligation(544)(545)576 576 
Total$(679)$(683)$576 $576 
Pension expense The following table shows the components of the pension cost recognized during each of the last three years. The amount for each year includes amortization of the prior service cost/credit and net actuarial loss/gain included in accumulated other comprehensive loss as of the beginning of the year. 
 Pension Benefits
 202320242025
Service cost$20 $18 $16 
Interest cost32 34 35 
Expected return on assets(43)(40)(38)
Amortization of:
Prior service cost (credit)
Net actuarial loss (gain)
Curtailment charge
— — 
Settlement charge29 — — 
Net cost$48 $19 $18 
Postretirement medical and life insurance benefit expense The following table shows the components of the postretirement medical and life insurance benefits cost that we recognized during each of the last three years. 
 Medical and Life Insurance Benefits
 202320242025
Service cost$$— $— 
Interest cost
Curtailment charge
— — 
Net cost$$$
Amounts recognized in other comprehensive income The following table shows the pre-tax effect of these amounts on OCI during each of the last three years.
 Pension BenefitsMedical and Life
Insurance Benefits
 202320242025202320242025
Prior service credit (cost)$— $(1)$— $— $— $— 
Net actuarial gain (loss)(29)20 (6)(2)
Amortization reclassified to earnings:
Prior service cost (credit)— — (1)
Net actuarial loss (gain)38 — — — 
Net amount recognized in OCI$10 $26 $(3)$$$(3)
Assumptions used in computing benefit plan obligations The weighted-average assumptions used in computing benefit plan obligations as of the end of the last two years were as follows:
 
Pension Benefits
Medical and Life
Insurance Benefits
 2024202520242025
Discount rate5.70 %5.62 %5.66 %5.45 %
Rate of salary increase4.00 %4.00 %n/an/a
Interest crediting rate4.79 %4.69 %n/an/a
Assumptions used in computing benefit plan expense
The weighted-average assumptions used in computing benefit plan cost during each of the last three years were as follows: 
 Pension BenefitsMedical and Life
Insurance Benefits
 202320242025202320242025
Discount rate for service cost4.52 %4.98 %5.74 %4.50 %5.02 %5.73 %
Discount rate for interest cost4.12 %4.79 %5.53 %3.96 %4.78 %5.49 %
Rate of salary increase4.00 %4.00 %4.00 %n/an/an/a
Interest crediting rate3.06 %3.69 %4.79 %n/an/an/a
Expected return on plan assets6.25 %6.50 %6.56 %n/an/an/a
Assumed health care cost trend rates
The assumed health care cost trend rates as of the end of the last two years were as follows: 
 Medical and Life
Insurance Benefits
 20242025
Health care cost trend rate assumed for next year7.13 %8.54 %
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)4.50 %4.50 %
Year that the rate reaches the ultimate trend rate20322034
v3.25.1
Stock-Based Compensation (Tables)
12 Months Ended
Apr. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Share-based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block] The following table presents information about SSARs outstanding as of April 30, 2025, and for the year then ended.
Number of
SSARs
(in thousands)
Weighted-
Average
Exercise Price
per SSAR
Weighted-
Average
Remaining
Contractual
Term (years)
Aggregate
Intrinsic Value
Outstanding at April 30, 2024
3,750 $55.37 
Granted595 44.97 
Exercised(19)39.58 
Forfeited or expired(448)42.98 
Outstanding at April 30, 2025
3,878 $55.29 4.6$— 
Exercisable at April 30, 2025
2,653 $53.25 3.1$— 
Schedule of Share-Based Payment Award, Stock Appreciation Rights, Valuation Assumptions [Table Text Block] The weighted-average grant-date fair values and related valuation assumptions for the SSARS granted during each of the last three years were as follows:
202320242025
Grant-date fair value$20.67 $21.69 $12.86 
Valuation assumptions:
Expected term (years)7.07.07.0
Risk-free interest rate2.7 %4.1 %4.1 %
Expected volatility24.8 %25.0 %26.1 %
Expected dividend yield1.0 %1.2 %1.9 %
Share-Based Payment Arrangement, PBRSU, Activity [Table Text Block]
The following table presents information about PBRSUs outstanding as of April 30, 2025, and for the year then ended.
Number of
PBRSUs
(in thousands)
Weighted-
Average
Fair Value at
Grant Date
Outstanding at April 30, 2024413 $76.53 
Granted356 $42.09 
Adjusted for performance and dividends(50)$70.04 
Converted to common shares(54)$70.04 
Forfeited(27)$48.81 
Outstanding at April 30, 2025638 $59.53 
Schedule of Share-Based Payment Award, Performance Based Restricted Stock Units, Valuation Assumptions [Table Text Block] The following table shows the assumptions used in the Monte Carlo simulation model to value the awards granted during each of the last three fiscal years.
202320242025
Valuation assumptions:
Risk-free interest rate2.8 %4.6 %4.3 %
Expected volatility29.8 %22.2 %24.6 %
Expected dividend yield1.0 %1.2 %1.9 %
Remaining performance period (years) as of grant date2.82.82.8
Share-based Payment Arrangement, Performance Based Restricted Stock Units, Activity [Table Text Block] The following table presents information about RSUs outstanding as of April 30, 2025, and for the year then ended.
Number of
RSUs
(in thousands)
Weighted-
Average
Fair Value at
Grant Date
Outstanding at April 30, 202487 $68.88 
Granted157 $44.65 
Additions for dividend equivalents$53.38 
Converted to common shares(30)$68.28 
Forfeited(10)$45.83 
Outstanding at April 30, 2025208 $51.51 
Grant Date Fair Values of DSUs [Table Text Block] The weighted average grant-date fair values for these awards granted during each of the last three years were as follows:
202320242025
Grant-date fair value$72.10 $71.23 $45.99 
Share-based Payment Arrangement, Cost by Plan [Table Text Block] The pre-tax stock-based compensation expense and related deferred income tax benefits recognized during the last three fiscal years were as follows:
202320242025
Pre-tax compensation expense$18 $25 $28 
Deferred tax benefit
Stock-Based Awards, Other Information [Table Text Block] Further information related to our stock-based awards for the last three years is as follows:
202320242025
Intrinsic value of SSARs exercised$19 $12 $— 
Fair value of shares vested
Tax benefit from exercise / vesting of awards
v3.25.1
Income Taxes (Tables)
12 Months Ended
Apr. 30, 2025
Income Tax Disclosure [Abstract]  
Domestic and Foreign income before Income taxes The following table, based on the locations of the taxable entities from which sales were derived (rather than the location of customers), presents the U.S. and foreign components of our income before income taxes:
202320242025
United States$841 $917 $826 
Foreign176 381 255 
$1,017 $1,298 $1,081 
Total income tax expense Our total income tax expense for each of the last three years was as follows:
202320242025
Current:
U.S. federal$157 $150 $173 
Foreign46 81 73 
State and local34 25 
237 256 251 
Deferred:
U.S. federal(4)16 (45)
Foreign(5)19 
State and local(5)(13)
(3)18 (39)
$234 $274 $212 
Reconciles our effective tax rate to the federal statutory tax rate in the United States The following table reconciles our effective tax rate to the federal statutory tax rate in the United States: 
 Percent of Income Before Taxes
 202320242025
U.S. federal statutory rate21.0 %21.0 %21.0 %
State taxes, net of U.S. federal tax benefit2.5 %1.3 %1.7 %
Income taxed at other than U.S. federal statutory rate3.0 %0.5 %1.5 %
Prior intercompany sales taxed at higher than current U.S. federal statutory rate1.0 %— %— %
Tax benefit from foreign-derived sales(3.0 %)(1.7 %)(2.8)%
Business divestitures
— %(0.7 %)— %
Adjustments related to prior years(0.5 %)— %(1.7)%
Excess tax benefits from stock-based awards(0.3 %)(0.1 %)— %
Tax rate changes— %0.4 %— %
Valuation allowance(1.3 %)0.1 %1.4 %
Other, net0.6 %0.4 %(1.5)%
Effective rate23.0 %21.2 %19.6 %
Deferred tax assets and liabilities
Deferred tax assets and liabilities as of the end of each of the last two years were as follows:
April 30,20242025
Deferred tax assets:
Postretirement and other benefits$65 $65 
Accrued liabilities and other29 44 
Inventories26 42 
Lease liabilities27 27 
Derivative instruments— 
Loss and credit carryforwards65 57 
Interest expense limitation carryforwards
18 23 
Total deferred tax assets230 260 
Valuation allowance(16)(35)
Total deferred tax assets, net of valuation allowance214 225 
Deferred tax liabilities:
Intangible assets(295)(294)
Property, plant, and equipment(93)(96)
Right-of-use assets(27)(27)
Derivative instruments(3)— 
Equity method investments
(37)— 
Other(5)(2)
Total deferred tax liabilities(460)(419)
Net deferred tax liability$(246)$(194)
Loss carryforwards and valuation allowances
Details of the loss, credit, and interest expense limitation carryforwards and related valuation allowances as of the end of each of the last two years are as follows:
April 30, 2024April 30, 2025
Gross AmountDeferred Tax AssetValuation AllowanceGross AmountDeferred Tax AssetValuation Allowance
Loss and credit carryforwards:
U.S.$110 $38 $(7)$68 $31 
1
$(10)
Foreign161 27 (9)135 26 
2
(15)
271 65 (16)203 57 (25)
Interest expense limitation carryforwards:
Foreign
74 18 — 91 23 
3
(10)
Total carryforwards
$345 $83 $(16)$294 $80 $(35)
1As of April 30, 2025, the deferred tax asset amount includes credit carryforwards of $12 that do not expire and loss and credit carryforwards of $19 that expire in varying amounts from 2026 to 2050.
2As of April 30, 2025, the deferred tax asset includes loss carryforwards of $23 that do not expire and $3 that expire in varying amounts over the next 10 years.
3The interest expense limitation carryforwards do not expire.
Reconciliation of ending and beginning unrecognized tax benefits A reconciliation of the beginning and ending unrecognized tax benefits follows: 
202320242025
Unrecognized tax benefits at beginning of year$14 $21 $14 
Additions for tax positions provided in prior periods— 
Additions for tax positions provided in current period
Decreases for tax positions provided in prior years— (3)— 
Settlements of tax positions in the current period— (3)— 
Lapse of statutes of limitations(4)(4)(3)
Unrecognized tax benefits at end of year$21 $14 $13 
v3.25.1
Derivative Financial Instruments and Hedging Activities (Tables)
12 Months Ended
Apr. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of fair values of derivative instruments affecting statements of operations
The following table presents the pre-tax impact that changes in the fair value of our derivative instruments and non-derivative hedging instruments had on AOCI and earnings during each of the last three years:
Classification in Statement of Operations202320242025
Currency derivatives designated as cash flow hedges:
Net gain (loss) recognized in AOCIn/a$$11 $(9)
Net gain (loss) reclassified from AOCI into earningsSales37 12 10 
Interest rate derivatives designated as cash flow hedges:
Net gain (loss) recognized in AOCIn/a(1)— — 
Currency derivatives not designated as hedging instruments:
Net gain (loss) recognized in earningsSales(1)— 
Net gain (loss) recognized in earningsOther income (expense), net16 (4)
Foreign currency-denominated debt designated as net investment hedge:
Net gain (loss) recognized in AOCIn/a(32)
Net gain (loss) reclassified from AOCI to earningsGain on business divestitures— 26 — 
Total amounts presented in the accompanying consolidated statements of operations for line items affected by the net gains (losses) shown above:
Sales5,372 5,328 5,056 
Gain on business divestitures
— 267 — 
Other income (expense), net(119)(24)52 
Schedule of fair values of derivative instruments
The following table presents the fair values of our derivative instruments as of April 30, 2024 and 2025:
Balance Sheet ClassificationDerivative AssetsDerivative Liabilities
April 30, 2024
Designated as cash flow hedges:
Currency derivativesOther current assets$11 $(2)
Currency derivativesOther assets(1)
Not designated as hedges:
Currency derivativesAccrued expenses— (1)
April 30, 2025
Designated as cash flow hedges:
Currency derivativesAccrued expenses(11)
Currency derivativesOther liabilities— (3)
Not designated as hedges:
Currency derivativesOther current assets— 
Offsetting Assets and Liabilities [Table Text Block]
The following table summarizes the gross and net amounts of our derivative contracts:
Gross Amounts of Recognized Assets (Liabilities)
Gross Amounts Offset in
Balance Sheet
Net Amounts Presented in Balance Sheet
Gross Amounts Not Offset in Balance Sheet
Net Amounts
April 30, 2024
Derivative assets$12 $(3)$$— $
Derivative liabilities(4)(1)— (1)
April 30, 2025
Derivative assets(2)— 
Derivative liabilities(14)(12)— (12)
v3.25.1
Fair Value Measurements (Tables)
12 Months Ended
Apr. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
The following table summarizes the assets and liabilities measured or disclosed at fair value on a recurring basis:
 20242025
April 30,Carrying
Amount
Fair
Value
Carrying
Amount
Fair
Value
Assets:
Cash and cash equivalents$446 $446 $444 $444 
Currency derivatives
Liabilities:
Currency derivatives12 12 
Contingent consideration
69 69 31 31 
Short-term borrowings428 428 312 312 
Long-term debt (including current portion)2,672 2,468 2,421 2,255 
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
The following table shows the changes in our contingent consideration liability:
Balance as of April 30, 2023
$63 
Purchase accounting adjustment
(1)
Change in fair value1
Foreign currency translation adjustment(2)
Balance as of April 30, 2024
69 
Change in fair value1
(43)
Foreign currency translation adjustment
Balance as of April 30, 2025
$31 
1Classified as “other expense (income), net” in the accompanying consolidated statement of operations.
v3.25.1
Leases (Tables)
12 Months Ended
Apr. 30, 2025
Leases [Abstract]  
ROU Assets and Lease Liabilities [Table Text Block]
The following table shows information about our leases as of the end of the last two years:
Balance Sheet ClassificationApril 30,
2024
April 30,
2025
Right-of-use assetsOther assets$96 $101 
Lease liabilities:
CurrentAccounts payable and accrued expenses$24 $26 
Non-currentOther liabilities73 78 
Total$97 $104 
Weighted-average discount rate4.2%4.5%
Weighted-average remaining term5.1 years4.8 years
Lease Cost and Other Lease Information [Table Text Block]
The following table shows information about the effects of leases during each of the last three years:
202320242025
Total lease cost1
$38 $51 $45 
Cash paid for amounts included in the measurement of lease liabilities2
25 29 30 
Right-of-use assets obtained in exchange for new lease liabilities29 38 33 
1Consists primarily of operating lease cost. Other components of lease cost were not material.
2Classified within operating activities in the accompanying consolidated statements of cash flows.
Lessee, Operating Lease, Liability, Maturity [Table Text Block]
The following table includes a maturity analysis of future (undiscounted) lease payments and a reconciliation of those payments to the lease liabilities recorded on our balance sheet as of April 30, 2025:
April 30,
2025
2026
$30 
2027
27 
2028
20 
2029
16 
2030
12 
Thereafter10 
Total lease payments115 
Less: Present value discount(11)
Lease liabilities$104 
v3.25.1
Other Comprehensive Income (Tables)
12 Months Ended
Apr. 30, 2025
Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Comprehensive Income (Loss) [Table Text Block]
The following table presents the components of net other comprehensive income (loss) during each of the last three years:
Pre-TaxTaxNet
Year Ended April 30, 2023
Currency translation adjustments:
Net gain (loss) on currency translation$135 $— $135 
Reclassification to earnings— — — 
Other comprehensive income (loss), net135 — 135 
Cash flow hedge adjustments:
Net gain (loss) on hedging instruments(1)
Reclassification to earnings1
(37)(29)
Other comprehensive income (loss), net(34)(27)
Postretirement benefits adjustments:
Net actuarial gain (loss) and prior service cost(26)(20)
Reclassification to earnings2
38 (9)29 
Other comprehensive income (loss), net12 (3)
Total other comprehensive income (loss), net$113 $$117 
Year Ended April 30, 2024
Currency translation adjustments:
Net gain (loss) on currency translation$(16)$(1)$(17)
Reclassification to earnings3
10 
Other comprehensive income (loss), net(12)(7)
Cash flow hedge adjustments:
Net gain (loss) on hedging instruments11 (2)
Reclassification to earnings1
(12)(9)
Other comprehensive income (loss), net(1)— 
Postretirement benefits adjustments:
Net actuarial gain (loss) and prior service cost22 (5)17 
Reclassification to earnings2
(2)
Other comprehensive income (loss), net28 (7)21 
Total other comprehensive income (loss), net$15 $(1)$14 
Year Ended April 30, 2025
Currency translation adjustments:
Net gain (loss) on currency translation$$10 $19 
Reclassification to earnings— — — 
Other comprehensive income (loss), net10 19 
Cash flow hedge adjustments:
Net gain (loss) on hedging instruments(9)(7)
Reclassification to earnings1
(10)(8)
Other comprehensive income (loss), net(19)(15)
Postretirement benefits adjustments:
Net actuarial gain (loss) and prior service cost(8)(5)
Reclassification to earnings2
— 
Other comprehensive income (loss), net(6)(3)
Total other comprehensive income (loss), net$(16)$17 $
1Pre-tax amount is classified as sales in the accompanying consolidated statements of operations.
2Pre-tax amount is classified as non-operating postretirement expense in the accompanying consolidated statements of operations.
3Pre-tax amount is classified in gain on business divestitures in the accompanying consolidated statements of operations.
v3.25.1
Segment and Other Information (Tables)
12 Months Ended
Apr. 30, 2025
Segment Reporting [Abstract]  
Net sales by geography
The following table presents consolidated net sales by country: 
202320242025
United States
$1,968 $1,889 $1,765 
Mexico
244 290 267 
Germany
239 263 253 
Australia
221 204 199 
United Kingdom
207 185 174 
Other1
1,349 1,347 1,317 
Total net sales
$4,228 $4,178 $3,975 
1Includes net sales of (a) branded products to countries not listed above; (b) branded products to global duty-free customers, other travel retail customers, and the U.S. military, regardless of customer location; and (c) used barrels, contract bottling services, and non-branded bulk whiskey, regardless of customer location.
v3.25.1
Accounting Policies Allowance for Doubtful Accounts (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Apr. 30, 2024
Allowance for Doubtful Accounts [Abstract]    
Accounts Receivable, Allowance for Credit Loss, Current $ 7 $ 8
v3.25.1
Accounting Policies (Textual) (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Apr. 30, 2024
Accounting Policies (Textual) [Abstract]    
Inventories valued using LIFO method (percent) 50.00%  
FIFO method value of inventory in excess of reported $ 600 $ 512
Minimum [Member] | Building Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life (years) 20 years  
Minimum [Member] | Machinery and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life (years) 3 years  
Minimum [Member] | Software [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life (years) 3 years  
Maximum [Member] | Building Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life (years) 40 years  
Maximum [Member] | Machinery and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life (years) 10 years  
Maximum [Member] | Software [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life (years) 7 years  
v3.25.1
Accounting Policies Revenue recognition policy (Details)
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Revenue recognition policy [Abstract]    
Revenue, Transaction Price Measurement, Tax Exclusion [true false] true true
v3.25.1
Accounting Policies Advertising expense policy (Details)
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Revenue recognition policy [Abstract]    
Advertising Cost, Expense Method [Fixed List] Expensed first time advertising takes place Expensed first time advertising takes place
v3.25.1
Accounting Policies GILTI tax accounting policy (Details)
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Accounting Policies [Abstract]    
GILTI Tax Accounting Policy [Fixed List] Tax as incurred Tax as incurred
v3.25.1
Balance Sheet Information (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Apr. 30, 2024
Property, plant, and equipment:    
Land $ 49 $ 49
Buildings 841 782
Equipment 869 928
Construction in process 180 181
Property, plant and equipment, gross 1,939 1,940
Less accumulated depreciation 844 866
Property, plant, and equipment, net 1,095 1,074
Accounts payable and accrued expenses:    
Accounts payable, trade 243 267
Accrued expenses:    
Advertising, promotion, and discounts 197 200
Compensation and commissions 86 105
Excise and other non-income taxes 67 67
Other 148 154
Accrued expenses 498 526
Accounts payable and accrued expenses 741 793
Other liabilities:    
Contingent consideration 31 69
Other 156 174
Other liabilities 187 243
Accumulated other comprehensive income (loss), net of tax:    
Currency translation adjustments (92) (111)
Cash flow hedge adjustments (5) 10
Postretirement benefits adjustments (123) (120)
Accumulated other comprehensive income (loss), net of tax: $ (220) $ (221)
v3.25.1
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Earnings Per Share [Abstract]      
Net income available to common stockholders, basic $ 869 $ 1,024 $ 783
Net income available to common stockholders, diluted $ 869 $ 1,024 $ 783
Share data (in thousands):      
Basic average common shares outstanding (shares) 472,655 476,394 479,155
Dilutive effect of stock-based awards (shares) 295 826 1,310
Diluted average common shares outstanding (shares) 472,950 477,220 480,465
Basic earnings per share (dollars per share) $ 1.84 $ 2.15 $ 1.63
Diluted earnings per share (dollars per share) $ 1.84 $ 2.14 $ 1.63
Antidilutive common stock-based awards excluded from calculation of diluted earnings per share (shares) 3,325 1,689 1,107
v3.25.1
Goodwill and Other Intangible Assets (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Goodwill [Roll Forward]      
Beginning balance $ 1,455 $ 1,457  
Purchase accounting adjustments   40  
Business divestitures   (28)  
Foreign currency translation adjustment 50 (14)  
Impairment 0 0  
Ending balance 1,505 1,455 $ 1,457
Indefinite-lived Intangible Assets [Roll Forward]      
Beginning balance 990 1,164  
Purchase accounting adjustments   (53)  
Business divestitures   (89)  
Foreign currency translation adjustment 38 (25)  
Impairment (47) (7) (96)
Ending balance $ 981 $ 990 $ 1,164
v3.25.1
Goodwill and Other Intangible Assets Impairment (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Indefinite-lived Intangible Assets [Line Items]      
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $ 47 $ 7 $ 96
Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration] Other income (expense), net Other income (expense), net  
v3.25.1
Equity Method Investments (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Schedule of Equity Method Investments [Line Items]      
Equity method investments $ 3 $ 270  
Related Party Transaction, Purchases from Related Party 24    
Proceeds from sale of equity method investment 350 $ 0 $ 0
Equity Method Investment, Realized Gain (Loss) on Disposal $ 78    
Duckhorn      
Schedule of Equity Method Investments [Line Items]      
Equity Method Investment, Ownership Percentage   21.40%  
Equity method investments   $ 267  
v3.25.1
Restructuring and Other Charges (Details Textual) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Jan. 13, 2025
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Percentage of Positions Eliminated   12.00%
Restructuring and Related Impairment Charges, Incurred to Date $ 48  
Inventory Write-down 3  
Restructuring Costs, Cash Payments to Date 27  
Impairment Charge [Member]    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Impairment Charges, Incurred to Date 2  
Restructuring Charges [Member]    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Impairment Charges, Incurred to Date 46  
Special Termination Benefits [Member]    
Restructuring Cost and Reserve [Line Items]    
Special Termination Benefit Costs, Incurred to Date $ 12  
Minimum [Member]    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost   $ 60
Maximum [Member]    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost   70
Severance and Other Employee-Related Costs [Member] | Minimum [Member]    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost   27
Severance and Other Employee-Related Costs [Member] | Maximum [Member]    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost   32
Other Restructuring Charges [Member] | Minimum [Member]    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost   33
Other Restructuring Charges [Member] | Maximum [Member]    
Restructuring Cost and Reserve [Line Items]    
Restructuring and Related Cost, Expected Cost   $ 38
v3.25.1
Restructuring and Other Charges (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Restructuring Cost and Reserve [Line Items]      
Restructuring charges $ 46    
Other charges [1] 14    
Total restructuring and other charges 60 $ 0 $ 0
Special Termination Benefits [Member]      
Restructuring Cost and Reserve [Line Items]      
Other charges 12    
Impairment Charge [Member]      
Restructuring Cost and Reserve [Line Items]      
Other charges 2    
Severance and Other Employee-Related Costs [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 24    
Other Restructuring Charges [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges [2] $ 22    
[1] Represents $12 in costs associated with a special one-time early retirement benefit to qualifying U.S. employees and $2 in impairment charges on certain cooperage facility assets held for sale.
[2] Primarily represents one-time costs related to the cooperage facility closure, consulting services, and other miscellaneous exit costs.
v3.25.1
Restructuring and Other Charges (Details 1)
$ in Millions
12 Months Ended
Apr. 30, 2025
USD ($)
Restructuring Reserve [Roll Forward]  
Balance at April 30, 2024 $ 0
Costs incurred and charged to expense 46
Costs paid or otherwise settled (27)
Balance at April 30, 2025 19
Severance and Other Employee-Related Costs [Member]  
Restructuring Reserve [Roll Forward]  
Balance at April 30, 2024 0
Costs incurred and charged to expense 24
Costs paid or otherwise settled (11)
Balance at April 30, 2025 13
Other Restructuring Charges [Member]  
Restructuring Reserve [Roll Forward]  
Balance at April 30, 2024 0
Costs incurred and charged to expense 22 [1]
Costs paid or otherwise settled (16)
Balance at April 30, 2025 $ 6
[1] Primarily represents one-time costs related to the cooperage facility closure, consulting services, and other miscellaneous exit costs.
v3.25.1
Debt and Credit Facilities (Schedule of Long-Term Debt) (Details)
€ in Millions, £ in Millions, $ in Millions
12 Months Ended
Apr. 15, 2025
USD ($)
Apr. 30, 2025
USD ($)
Apr. 30, 2024
USD ($)
Apr. 30, 2023
USD ($)
Apr. 30, 2025
EUR (€)
Apr. 30, 2025
GBP (£)
Apr. 30, 2024
EUR (€)
Apr. 30, 2024
GBP (£)
Debt Instrument [Line Items]                
Total long term debt   $ 2,421 $ 2,672          
Current portion of long-term debt   0 300          
Long-term debt   2,421 2,372          
Repayment of long-term debt   300 0 $ 250        
3.50% senior notes, due April 15, 2025 [Member]                
Debt Instrument [Line Items]                
Debt Instrument, Face Amount $ 300 $ 300 $ 300          
Debt Instrument, Maturity Date Apr. 15, 2025 Apr. 15, 2025 Apr. 15, 2025          
Debt Instrument, Interest Rate, Stated Percentage 3.50% 3.50% 3.50%   3.50% 3.50% 3.50% 3.50%
Total long term debt   $ 0 $ 300          
Repayment of long-term debt $ 300              
1.20% senior notes, due July 7, 2026 [Member]                
Debt Instrument [Line Items]                
Debt Instrument, Face Amount | €         € 300   € 300  
Debt Instrument, Maturity Date   Jul. 07, 2026 Jul. 07, 2026          
Debt Instrument, Interest Rate, Stated Percentage   1.20% 1.20%   1.20% 1.20% 1.20% 1.20%
Total long term debt   $ 342 $ 321          
2.60% senior notes, due July 7, 2028 [Member]                
Debt Instrument [Line Items]                
Debt Instrument, Face Amount | £           £ 300   £ 300
Debt Instrument, Maturity Date   Jul. 07, 2028 Jul. 07, 2028          
Debt Instrument, Interest Rate, Stated Percentage   2.60% 2.60%   2.60% 2.60% 2.60% 2.60%
Total long term debt   $ 401 $ 375          
4.75% senior notes, due April 15, 2033 {Member}                
Debt Instrument [Line Items]                
Debt Instrument, Face Amount   $ 650 $ 650          
Debt Instrument, Maturity Date   Apr. 15, 2033 Apr. 15, 2033          
Debt Instrument, Interest Rate, Stated Percentage   4.75% 4.75%   4.75% 4.75% 4.75% 4.75%
Total long term debt   $ 644 $ 643          
4.00% senior notes, due April 15, 2038 [Member]                
Debt Instrument [Line Items]                
Debt Instrument, Face Amount   $ 300 $ 300          
Debt Instrument, Maturity Date   Apr. 15, 2038 Apr. 15, 2038          
Debt Instrument, Interest Rate, Stated Percentage   4.00% 4.00%   4.00% 4.00% 4.00% 4.00%
Total long term debt   $ 296 $ 295          
3.75% senior notes, due January 15, 2043 [Member]                
Debt Instrument [Line Items]                
Debt Instrument, Face Amount   $ 250 $ 250          
Debt Instrument, Maturity Date   Jan. 15, 2043 Jan. 15, 2043          
Debt Instrument, Interest Rate, Stated Percentage   3.75% 3.75%   3.75% 3.75% 3.75% 3.75%
Total long term debt   $ 248 $ 248          
4.50% senior notes, due July 15, 2045 [Member]                
Debt Instrument [Line Items]                
Debt Instrument, Face Amount   $ 500 $ 500          
Debt Instrument, Maturity Date   Jul. 15, 2045 Jul. 15, 2045          
Debt Instrument, Interest Rate, Stated Percentage   4.50% 4.50%   4.50% 4.50% 4.50% 4.50%
Total long term debt   $ 490 $ 490          
v3.25.1
Debt and Credit Facilities (Textual) (Details)
$ in Millions
Apr. 30, 2025
USD ($)
Long-term Debt, Fiscal Year Maturity [Abstract]  
2025 $ 0
2026 342
2027 0
2028 402
2029 0
After 2029 $ 1,700
v3.25.1
Debt and Credit Facilities Short-term borrowings (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Short-Term Debt [Abstract]    
Commercial Paper $ 313 $ 429
Commercial Paper, Weighted Average Interest Rate, at Point in Time 4.64% 5.49%
Commercial Paper Borrowings, Average Remaining Maturity 12 days 12 days
v3.25.1
Debt and Credit Facilities Credit Facilities (Details)
$ in Millions
Apr. 30, 2025
USD ($)
Line of Credit Facility [Abstract]  
Line of Credit Facility, Current Borrowing Capacity $ 900
v3.25.1
Common Stock Rollforward of Outstanding Shares (Details) - shares
shares in Thousands
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Class of Stock [Line Items]      
Beginning balance 472,600 479,316 479,020
Acquisition of treasury stock   (6,912)  
Stock issued under compensation plans 69 196 296
Ending balance 472,669 472,600 479,316
Class A Common Stock      
Class of Stock [Line Items]      
Beginning balance 169,108 169,240 169,175
Acquisition of treasury stock   (176)  
Stock issued under compensation plans 21 44 65
Ending balance 169,129 169,108 169,240
Class B Common Stock      
Class of Stock [Line Items]      
Beginning balance 303,492 310,076 309,845
Acquisition of treasury stock   (6,736)  
Stock issued under compensation plans 48 152 231
Ending balance 303,540 303,492 310,076
v3.25.1
Net Sales by Geography (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Disaggregation of Revenue [Line Items]      
Net sales $ 3,975 $ 4,178 $ 4,228
United States      
Disaggregation of Revenue [Line Items]      
Net sales 1,765 1,889 1,968
Developed International [Member]      
Disaggregation of Revenue [Line Items]      
Net sales [1] 1,090 1,154 1,178
Emerging [Member]      
Disaggregation of Revenue [Line Items]      
Net sales [2] 852 869 824
Travel Retail [Member]      
Disaggregation of Revenue [Line Items]      
Net sales [3] 166 179 170
Non-branded and bulk [Member]      
Disaggregation of Revenue [Line Items]      
Net sales [4] $ 102 $ 87 $ 88
[1] Represents net sales of branded products to “advanced economies” as defined by the International Monetary Fund (IMF), excluding the United States. Our top developed international markets are Germany, Australia, the United Kingdom, France, and Canada.
[2] Represents net sales of branded products to “emerging and developing economies” as defined by the IMF. Our top emerging markets are Mexico, Poland, Brazil, and Türkiye.
[3] Represents net sales of branded products to global duty-free customers, other travel retail customers, and the U.S. military, regardless of customer location.
[4] Includes net sales of used barrels, contract bottling services, and non-branded bulk whiskey, regardless of customer location.
v3.25.1
Net Sales by Product Category (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Disaggregation of Revenue [Line Items]      
Net sales $ 3,975 $ 4,178 $ 4,228
Whiskey [Member]      
Disaggregation of Revenue [Line Items]      
Net sales [1] 2,828 2,832 2,915
Ready-to-Drink [Member]      
Disaggregation of Revenue [Line Items]      
Net sales [2] 491 520 509
Tequila [Member]      
Disaggregation of Revenue [Line Items]      
Net sales [3] 262 306 320
Non-branded and bulk [Member]      
Disaggregation of Revenue [Line Items]      
Net sales [4] 102 87 88
Rest of portfolio [Member]      
Disaggregation of Revenue [Line Items]      
Net sales [5] $ 292 $ 433 $ 396
[1] Includes all whiskey spirits and whiskey-based flavored liqueurs. The brands included in this category are the Jack Daniel’s family of brands (excluding the “Ready-to-Drink” products outlined below), the Woodford Reserve family of brands, the Old Forester family of brands, The Glendronach, Benriach, Glenglassaugh, and Slane Irish Whiskey.
[2] Includes the Jack Daniel’s ready-to-drink (RTD) and ready-to-pour (RTP) products, New Mix, and other RTD/RTP products.
[3] Includes el Jimador, the Herradura family of brands, and other tequilas.
[4] Includes net sales of used barrels, contract bottling services, and non-branded bulk whiskey.
[5] Includes Korbel California Champagnes and Korbel Brandy (announced the end of the sales, marketing, and distribution relationship effective June 30, 2025), Diplomático, Chambord, Gin Mare, Sonoma-Cutrer (which was divested on April 30, 2024), Finlandia Vodka (which was divested on November 1, 2023), Fords Gin, and other agency brands (brands we do not own, but sell in certain markets).
v3.25.1
Pension and Other Postretirement Benefits (Change in Benefit Obligation) (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Pension Benefits [Member]      
Changes in present value of pension and other postretirement benefits      
Obligation at beginning of year $ 679 $ 731  
Service cost 16 18 $ 20
Interest cost 35 34 32
Net actuarial loss (gain)1 [1] 5 (61)  
Plan amendments 0 1  
Retiree contributions 0 0  
Benefits paid (52) (44)  
Special termination benefits 0 0  
Obligation at end of year 683 679 731
Medical and Life Insurance Benefits [Member]      
Changes in present value of pension and other postretirement benefits      
Obligation at beginning of year 36 40  
Service cost 0 0 1
Interest cost 2 2 1
Net actuarial loss (gain)1 [1] 3 (3)  
Plan amendments 0 0  
Retiree contributions 2 3  
Benefits paid (5) (6)  
Special termination benefits 1 0  
Obligation at end of year $ 39 $ 36 $ 40
[1] The net actuarial loss (gain) during each year was primarily attributable to changes in discount rates
v3.25.1
Pension and Other Postretirement Benefits (Expected Benefit Payments) (Details)
$ in Millions
Apr. 30, 2025
USD ($)
Pension Benefits [Member]  
Expected benefit payments over the next 10 years  
2026 $ 105
2027 50
2028 51
2029 52
2030 52
2031 – 2035 260
Medical and Life Insurance Benefits [Member]  
Expected benefit payments over the next 10 years  
2026 4
2027 4
2028 4
2029 4
2030 3
2031 – 2035 $ 15
v3.25.1
Pension and Other Postretirement Benefits Target asset allocation (Details)
Apr. 30, 2025
Public Equity Investments [Member]  
Defined Benefit Plan Disclosure [Line Items]  
Defined Benefit Plan, Plan Assets, Target Allocation, Percentage 26.00%
Fixed Income Investments [Member]  
Defined Benefit Plan Disclosure [Line Items]  
Defined Benefit Plan, Plan Assets, Target Allocation, Percentage 59.00%
Alternative Investments [Member]  
Defined Benefit Plan Disclosure [Line Items]  
Defined Benefit Plan, Plan Assets, Target Allocation, Percentage 15.00%
v3.25.1
Pension and Other Postretirement Benefits (Fair Value of Pension Plan Assets and Asset Allocations) (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Apr. 30, 2024
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets $ 576 $ 576
Level 1 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets 25 31
Level 2 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets 242 278
Level 3 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets 1 1
Fair Value, Inputs, Level 1, 2 and 3 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets 268 310
Equity Securities [Member] | Level 1 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets 25 31
Equity Securities [Member] | Level 2 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets 0 0
Equity Securities [Member] | Level 3 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets 0 0
Equity Securities [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets 25 31
Fixed Income Investments [Member] | Level 1 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets 0 0
Fixed Income Investments [Member] | Level 2 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets 242 278
Fixed Income Investments [Member] | Level 3 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets 0 0
Fixed Income Investments [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets 242 278
Limited Partnership Interests [Member] | Level 1 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets [1] 0 0
Limited Partnership Interests [Member] | Level 2 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets [1] 0 0
Limited Partnership Interests [Member] | Level 3 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets [1] 1 1
Limited Partnership Interests [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets [1] 1 1
Limited Partnership Interests [Member] | Fair Value Measured at Net Asset Value Per Share [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets [2] 47 38
Equity Funds [Member] | Fair Value Measured at Net Asset Value Per Share [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets [3] 115 118
Fixed Income Funds [Member] | Fair Value Measured at Net Asset Value Per Share [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets [3] 28 53
Real Estate funds [Member] | Fair Value Measured at Net Asset Value Per Share [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets [3] 41 49
Short-term Investments [Member] | Fair Value Measured at Net Asset Value Per Share [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets [3] 75 11
Net receivable (payable) for pending transactions [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total, Plan Assets $ 2 $ (3)
[1] This limited partnership interest was initially valued at cost and has been adjusted to fair value as determined in good faith by management of the partnership using various factors, and does not meet the requirements for reporting at the net asset value (NAV). The valuation requires significant judgment due to the absence of quoted market prices and the inherent lack of liquidity. This limited partnership has a term expiring in September 2025.
[2] These limited partnership interests were initially valued at cost and have been adjusted using NAV per audited financial statements. Investments are generally not eligible for immediate redemption and have original terms averaging 10 to 13 years, although those periods may be extended.
[3] Commingled trust fund valuations are based on the NAV of the funds as determined by the fund administrators and reviewed by us. NAV represents the underlying assets owned by the fund, minus liabilities and divided by the number of shares or units outstanding. Generally, for commingled trust funds other than real estate, redemptions are permitted daily with no notice period. The real estate fund is redeemable quarterly with 110 days’ notice.
v3.25.1
Pension and Other Postretirement Benefits (Change in Fair Value of Pension Plan Assets) (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Change in fair value of pension plan Assets    
Beginning balance $ 576  
Ending balance 576 $ 576
Pension Benefits [Member]    
Change in fair value of pension plan Assets    
Beginning balance 576 606
Actual return on assets 36 (2)
Retiree contributions 0 0
Company contributions 16 16
Benefits paid (52) (44)
Ending balance 576 576
Medical and Life Insurance Benefits [Member]    
Change in fair value of pension plan Assets    
Beginning balance 0 0
Actual return on assets 0 0
Retiree contributions 2 3
Company contributions 3 3
Benefits paid (5) (6)
Ending balance $ 0 $ 0
v3.25.1
Pension and Other Postretirement Benefits (Funded Status of Plans) (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Funded Status of Plans      
Assets $ 576 $ 576  
Pension Benefits [Member]      
Funded Status of Plans      
Assets 576 576 $ 606
Obligations (683) (679) (731)
Funded status (107) (103)  
Medical and Life Insurance Benefits [Member]      
Funded Status of Plans      
Assets 0 0 0
Obligations (39) (36) $ (40)
Funded status $ (39) $ (36)  
v3.25.1
Pension and Other Postretirement Benefits (Funded Status Recorded on Accompanying Balance Sheets) (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Apr. 30, 2024
Funded status is recorded on the accompanying consolidated balance sheets    
Accrued pension and other postretirement benefits $ (164) $ (160)
Pension Benefits [Member]    
Funded status is recorded on the accompanying consolidated balance sheets    
Other assets 31 32
Accounts payable and accrued expenses (9) (8)
Accrued pension and other postretirement benefits (129) (127)
Net liability (107) (103)
Accumulated other comprehensive income (loss), before tax:    
Net actuarial gain (loss) (171) (166)
Prior service credit (cost) (2) (4)
Total (173) (170)
Medical and Life Insurance Benefits [Member]    
Funded status is recorded on the accompanying consolidated balance sheets    
Other assets 0 0
Accounts payable and accrued expenses (4) (3)
Accrued pension and other postretirement benefits (35) (33)
Net liability (39) (36)
Accumulated other comprehensive income (loss), before tax:    
Net actuarial gain (loss) 0 2
Prior service credit (cost) 1 1
Total $ 1 $ 3
v3.25.1
Pension and Other Postretirement Benefits (Plans with ABO in Excess of Plan Assets) (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Total, Plan Assets $ 576 $ 576  
Pension Plan [Member]      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation (128) (124)  
Defined Benefit Plan Pension Plans With Assets In Excess Of Accumulated Benefit Obligation Aggregate Accumulated Benefit Obligation (507) (487)  
Defined Benefit Plan, Accumulated Benefit Obligation (635) (611)  
Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets 0 0  
Defined Benefit Plan Pension Plans With Assets In Excess Of Accumulated Benefit Obligation Aggregate Fair Value Of Plan Assets 576 576  
Total, Plan Assets $ 576 $ 576 $ 606
v3.25.1
Pension and Other Postretirement Benefits (Plans with PBO in Excess of Plan Assets) (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Total, Plan Assets $ 576 $ 576  
Pension Plan [Member]      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation (138) (135)  
Defined Benefit Plan, Pension Plan with Plan Assets in Excess of Projected Benefit Obligation, Projected Benefit Obligation (545) (544)  
Defined Benefit Plan, Benefit Obligation (683) (679) $ (731)
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets 0 0  
Defined Benefit Plan, Pension Plan with Plan Assets in Excess of Projected Benefit Obligation, Plan Assets 576 576  
Total, Plan Assets $ 576 $ 576 $ 606
v3.25.1
Pension and Other Postretirement Benefits (Schedule of Components of Pension Expense) (Details) - Pension Benefits [Member] - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Pension Expense      
Service cost $ 16 $ 18 $ 20
Interest cost 35 34 32
Expected return on assets (38) (40) (43)
Amortization of prior service cost (credit) 1 1 1
Amortization of net actuarial loss (gain) 2 6 9
Curtailment charge 2 0 0
Settlement charge 0 0 29
Net cost $ 18 $ 19 $ 48
v3.25.1
Pension and Other Postretirement Benefits (Schedule of Components of Other Postretirement Benefit Expense) (Details) - Medical and Life Insurance Benefits [Member] - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Postretirement medical and life insurance benefit expense      
Service cost $ 0 $ 0 $ 1
Interest cost 2 2 1
Curtailment charge 1 0 0
Net cost $ 3 $ 2 $ 2
v3.25.1
Pension and Other Postretirement Benefits (Changes in Funded Status of Benefit Plans Recognized in Other Comprehensive (Income) Loss) (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Pension Benefits [Member]      
Amounts recognized in OCI      
Prior service credit (cost) $ 0 $ (1) $ 0
Net actuarial gain (loss) (6) 20 (29)
Amortization reclassified to earnings:      
Prior service cost (credit) 1 1 1
Net actuarial loss (gain) 2 6 38
Net amount recognized in OCI (3) 26 10
Medical and Life Insurance Benefits [Member]      
Amounts recognized in OCI      
Prior service credit (cost) 0 0 0
Net actuarial gain (loss) (2) 3 2
Amortization reclassified to earnings:      
Prior service cost (credit) (1) 0 0
Net actuarial loss (gain) 0 0 0
Net amount recognized in OCI $ (3) $ 3 $ 2
v3.25.1
Pension and Other Postretirement Benefits (Assumptions and SensItivity) (Details)
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Pension Benefits [Member]      
Assumptions used in computing benefit plan obligations      
Discount rate (percent) 5.62% 5.70%  
Rate of salary increase (percent) 4.00% 4.00%  
Interest crediting rate (percent) 4.69% 4.79%  
Assumptions used in computing benefit plan expense      
Discount rate for service cost (percent) 5.74% 4.98% 4.52%
Discount rate for interest cost (percent) 5.53% 4.79% 4.12%
Rate of salary increase (percent) 4.00% 4.00% 4.00%
Interest crediting rate (percent) 4.79% 3.69% 3.06%
Expected return on plan assets (percent) 6.56% 6.50% 6.25%
Medical and Life Insurance Benefits [Member]      
Assumptions used in computing benefit plan obligations      
Discount rate (percent) 5.45% 5.66%  
Assumptions used in computing benefit plan expense      
Discount rate for service cost (percent) 5.73% 5.02% 4.50%
Discount rate for interest cost (percent) 5.49% 4.78% 3.96%
Assumed health care cost trend rates      
Health care cost trend rate assumed for next year (percent) 8.54% 7.13%  
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate) (percent) 4.50% 4.50%  
v3.25.1
Pension and Other Postretirement Benefits Sponsor Location (Details)
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Pension Plan [Member]    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Defined Benefit Plan, Sponsor Location [Extensible List] Domestic Plan [Member] Domestic Plan [Member]
Other Postretirement Benefits Plan [Member]    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Defined Benefit Plan, Sponsor Location [Extensible List] Domestic Plan [Member] Domestic Plan [Member]
v3.25.1
Pension and Other Postretirement Benefits (Textual) (Details)
$ in Millions
Apr. 30, 2025
USD ($)
Pension Benefits [Member]  
Defined Benefit Plan Disclosure [Line Items]  
Expected contribution to benefit plans in 2023 $ 16
Medical and Life Insurance Benefits [Member]  
Defined Benefit Plan Disclosure [Line Items]  
Expected contribution to benefit plans in 2023 $ 4
v3.25.1
Pension and Other Postretirement Benefits (Savings Plans) (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Retirement Benefits [Abstract]      
Expense for matching contributions $ 13 $ 14 $ 14
v3.25.1
Stock-Based Compensation (Details)
Apr. 30, 2025
shares
Share-Based Payment Arrangement [Abstract]  
Shares authorized under 2022 Omnibus Compensation Plan (shares) 12,412,433
Share remaining available for issuance under 2022 Omnibus Compensation Plan (shares) 10,640,000
v3.25.1
Stock-Based Compensation SSARs (Details) - Stock Appreciation Rights (SARs) [Member]
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended
Apr. 30, 2025
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Outstanding, beginning balance | shares 3,750
Granted | shares 595
Exercised | shares (19)
Forfeited or expired | shares (448)
Outstanding, ending balance | shares 3,878
Exercisable | shares 2,653
Weighted Average Exercise Price [Roll Forward]  
Weighted average exercise price, beginning | $ / shares $ 55.37
Weighted average exercise price, grants in period | $ / shares 44.97
Weighted average exercise price, exercises in period | $ / shares 39.58
Weighted average exercise price, forfeitures and expirations in period | $ / shares 42.98
Weighted average exercise price, ending | $ / shares 55.29
Weighted average exercise price, exercisable | $ / shares $ 53.25
Weighted Average Remaining Contractual Term (years) 4 years 7 months 6 days
Weighted Average Remaining Contractual Term (years) 3 years 1 month 6 days
SSARs outstanding, Aggregate Intrinsic Value | $ $ 0
SSARs exercisable, Aggregate Intrinsic Value | $ $ 0
v3.25.1
Stock-Based Compensation SSARs Fair Value Assumptions (Details) - Stock Appreciation Rights (SARs) [Member] - $ / shares
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Grant-date fair value $ 12.86 $ 21.69 $ 20.67
Expected term (years) 7 years 7 years 7 years
Risk-free interest rate (percent) 4.10% 4.10% 2.70%
Expected volatility (percent) 26.10% 25.00% 24.80%
Expected dividend yield (percent) 1.90% 1.20% 1.00%
v3.25.1
Stock-Based Compensation PBRSUs (Details) - PBRSU [Member]
shares in Thousands
12 Months Ended
Apr. 30, 2025
$ / shares
shares
Number of PBRSUs [Roll Forward]  
Outstanding, beginning balance | shares 413
Granted | shares 356
Adjusted for performance and dividends | shares (50)
Converted to common shares (shares) | shares (54)
Forfeited | shares (27)
Outstanding, ending balance | shares 638
Weighted Average Fair Value at Grant Date [Roll Forward]  
Weighted Average Fair Value at Grant Date, Outstanding, Beginning | $ / shares $ 76.53
Weighted Average Fair Value at Grant Date, Granted | $ / shares 42.09
Weighted Average Fair Value at Grant Date, Adjusted for Performance and Dividends | $ / shares 70.04
Weighted Average Fair Value at Grant Date, Converted to Common Shares | $ / shares 70.04
Weighted Average Fair Value at Grant Date, Forfeited | $ / shares 48.81
Weighted Average Fair Value at Grant Date, Outstanding, Ending | $ / shares $ 59.53
v3.25.1
Stock-Based Compensation PBRSUs Fair Value Assumptions (Details) - PBRSU [Member]
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Risk-free interest rate (percent) 4.30% 4.60% 2.80%
Expected volatility (percent) 24.60% 22.20% 29.80%
Expected dividend yield (percent) 1.90% 1.20% 1.00%
Remaining performance period (years) as of grant date 2 years 9 months 18 days 2 years 9 months 18 days 2 years 9 months 18 days
v3.25.1
Stock-Based Compensation RSUs (Details) - Restricted Stock Units (RSUs) [Member]
shares in Thousands
12 Months Ended
Apr. 30, 2025
$ / shares
shares
Number of RSUs [Roll Forward]  
Outstanding, beginning balance | shares 87
Granted | shares 157
Additions for dividend equivalents | shares 4
Converted to common shares (shares) | shares (30)
Forfeited | shares (10)
Outstanding, ending balance | shares 208
Weighted Average Fair Value at Grant Date [Roll Forward]  
Weighted Average Fair Value at Grant Date, Outstanding, Beginning | $ / shares $ 68.88
Weighted Average Fair Value at Grant Date, Granted | $ / shares 44.65
Weighted Average Fair Value at Grant Date, Additions for Dividend Equivalents | $ / shares 53.38
Weighted Average Fair Value at Grant Date, Converted to Common Shares | $ / shares 68.28
Weighted Average Fair Value at Grant Date, Forfeited | $ / shares 45.83
Weighted Average Fair Value at Grant Date, Outstanding, Ending | $ / shares $ 51.51
v3.25.1
Stock-Based Compensation DSUs (Details) - Deferred Stock Units (DSUs) [Member] - $ / shares
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 215,000    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 180,000    
Grant-date fair value $ 45.99 $ 71.23 $ 72.10
v3.25.1
Stock-Based Compensation Additional Information (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Pre-tax compensation expense $ 28 $ 25 $ 18
Deferred tax benefit 3 3 3
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $ 15    
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition 1 year 6 months    
Intrinsic value of SSARs exercised $ 0 12 19
Fair value of shares vested 5 4 6
Tax benefit from exercise / vesting of awards $ 1 $ 3 $ 4
v3.25.1
Income Taxes (Schedule of Income from U.S. and Foreign Operations) (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Domestic and Foreign components of our Income before Income taxes      
United States $ 826 $ 917 $ 841
Foreign 255 381 176
Income before income taxes $ 1,081 $ 1,298 $ 1,017
v3.25.1
Income Taxes (Components of Income Tax Expense) (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Current:      
U.S. federal $ 173 $ 150 $ 157
Foreign 73 81 46
State and local 5 25 34
Current income tax expense 251 256 237
Deferred:      
U.S. federal (45) 16 (4)
Foreign 19 (5) 6
State and local (13) 7 (5)
Deferred income taxes expense (39) 18 (3)
Total income tax expense $ 212 $ 274 $ 234
v3.25.1
Income Taxes (Effective Tax Rate Reconciliation) (Details)
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Reconciles our effective tax rate to the federal statutory tax rate in the United States      
U.S. federal statutory rate 21.00% 21.00% 21.00%
State taxes, net of U.S. federal tax benefit 1.70% 1.30% 2.50%
Income taxed at other than U.S. federal statutory rate 1.50% 0.50% 3.00%
Prior intercompany sales taxed at higher than current U.S. federal statutory rate 0.00% 0.00% 1.00%
Tax benefit from foreign-derived sales (2.80%) (1.70%) (3.00%)
Business divestitures 0.00% (0.70%) 0.00%
Adjustments related to prior years (1.70%) 0.00% (0.50%)
Excess tax benefits from stock-based awards 0.00% (0.10%) (0.30%)
Tax rate changes 0.00% 0.40% 0.00%
Valuation allowance 1.40% 0.10% (1.30%)
Other, net (1.50%) 0.40% 0.60%
Effective rate 19.60% 21.20% 23.00%
v3.25.1
Income Taxes (Deferred Tax Assets and Liabilities) (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Apr. 30, 2024
Deferred tax assets:    
Postretirement and other benefits $ 65 $ 65
Accrued liabilities and other 44 29
Inventories 42 26
Lease liabilities 27 27
Derivative instruments 2 0
Loss and credit carryforwards 57 65
Interest expense limitation carryforwards 23 [1] 18
Total deferred tax assets 260 230
Valuation allowance (35) (16)
Total deferred tax assets, net of valuation allowance 225 214
Deferred tax liabilities:    
Intangible assets (294) (295)
Property, plant, and equipment (96) (93)
Right-of-use assets (27) (27)
Derivative instruments 0 (3)
Equity method investments 0 (37)
Other (2) (5)
Total deferred tax liabilities (419) (460)
Net deferred tax liability $ (194) $ (246)
[1] The interest expense limitation carryforwards do not expire.
v3.25.1
Income Taxes (Loss Carryforwards) (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Apr. 30, 2024
Operating Loss Carryforwards [Line Items]    
Loss and Credit Carryforwards $ 203 $ 271
Deferred Tax Assets, Loss and Credit Carryforwards 57 65
Loss and Credit Carryforwards, Valuation Allowance (25) (16)
Interest Carryforwards 91 74
Deferred Tax Asset, Interest Carryforward 23 [1] 18
Interest Carryforwards, Valuation Allowance (10) 0
Total Carryforwards 294 345
Deferred Tax Asset, Total Carryforwards 80 83
Total Carryforwards, Valuation Allowance (35) (16)
Domestic Tax Authority    
Operating Loss Carryforwards [Line Items]    
Loss and Credit Carryforwards 68 110
Deferred Tax Assets, Loss and Credit Carryforwards 31 [2] 38
Loss and Credit Carryforwards, Valuation Allowance (10) (7)
Domestic Tax Authority | Not Subject to Expiration [Member]    
Operating Loss Carryforwards [Line Items]    
Deferred Tax Assets, Loss and Credit Carryforwards 12  
Domestic Tax Authority | Subject to Expiration [Member]    
Operating Loss Carryforwards [Line Items]    
Deferred Tax Assets, Loss and Credit Carryforwards 19  
Foreign Tax Authority [Member]    
Operating Loss Carryforwards [Line Items]    
Loss and Credit Carryforwards 135 161
Deferred Tax Assets, Loss and Credit Carryforwards 26 [3] 27
Loss and Credit Carryforwards, Valuation Allowance (15) $ (9)
Foreign Tax Authority [Member] | Not Subject to Expiration [Member]    
Operating Loss Carryforwards [Line Items]    
Deferred Tax Assets, Loss and Credit Carryforwards 23  
Foreign Tax Authority [Member] | Subject to Expiration [Member]    
Operating Loss Carryforwards [Line Items]    
Deferred Tax Assets, Loss and Credit Carryforwards $ 3  
[1] The interest expense limitation carryforwards do not expire.
[2] As of April 30, 2025, the deferred tax asset amount includes credit carryforwards of $12 that do not expire and loss and credit carryforwards of $19 that expire in varying amounts from 2026 to 2050.
[3] As of April 30, 2025, the deferred tax asset includes loss carryforwards of $23 that do not expire and $3 that expire in varying amounts over the next 10 years.
v3.25.1
Income Taxes (Earnings of Foreign Subsidiaries) (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Apr. 30, 2024
Income Tax Disclosure [Abstract]    
Undistributed Earnings of Foreign Subsidiaries $ 1,890 $ 1,909
v3.25.1
Income Taxes (Unrecognized Tax Benefits) (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Reconciliation of Unrecognized Tax Benefits [Roll Forward]      
Unrecognized tax benefits at beginning of year $ 14 $ 21 $ 14
Additions for tax positions provided in prior periods 0 1 8
Additions for tax positions provided in current period 2 2 3
Decreases for tax positions provided in prior years 0 (3) 0
Settlements of tax positions in the current period 0 (3) 0
Lapse of statutes of limitations (3) (4) (4)
Unrecognized tax benefits at end of year 13 $ 14 $ 21
Unrecognized Tax Benefits [Abstract]      
Unrecognized Tax Benefits that Would Impact Effective Tax Rate 11    
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit $ 0    
v3.25.1
Acquisitions (Details)
€ in Millions, $ in Millions
12 Months Ended
Jan. 05, 2023
USD ($)
Nov. 03, 2022
USD ($)
Apr. 30, 2023
USD ($)
Apr. 30, 2025
USD ($)
Apr. 30, 2024
USD ($)
Nov. 03, 2022
EUR (€)
Business Acquisition [Line Items]            
Contingent consideration, Carrying Amount       $ 31 $ 69  
Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed     $ 55      
Gin Mare            
Business Acquisition [Line Items]            
Business Acquisition, Percentage of Voting Interests Acquired   100.00%       100.00%
Business Combination, Consideration Transferred   $ 523        
Payments to Acquire Businesses, Gross   468        
Contingent consideration, Carrying Amount   $ 55        
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High | €           € 90
Supply Agreement, Term   10 years        
Diplomatico            
Business Acquisition [Line Items]            
Business Acquisition, Percentage of Voting Interests Acquired 100.00%          
Payments to Acquire Businesses, Gross $ 723          
Supply Agreement, Term 10 years          
Diplomatico | Adjustments {Member]            
Business Acquisition [Line Items]            
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net $ 4          
v3.25.1
Gain on Business Divestitures (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Cash proceeds $ 0 $ 246 $ 0
Pre-tax gain on divestiture of business $ 0 $ 267 $ 0
Duckhorn      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Equity Method Investment, Ownership Percentage   21.40%  
Finlandia      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Cash proceeds   $ 196  
Pre-tax gain on divestiture of business   92  
Sonoma-Cutrer      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Cash proceeds   50  
Pre-tax gain on divestiture of business   $ 175  
v3.25.1
Derivative Financial Instruments and Hedging Activities (Gain (Loss) on Derivatives Recognized in Consolidated Statement of Operations) (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Total amounts presented in the accompanying condensed consolidated statements of operations for line items affected by the net gains (losses) shown above: [Abstract]      
Sales $ 5,056 $ 5,328 $ 5,372
Gain on business divestitures 0 267 0
Other income (expense), net 52 (24) (119)
Foreign Currency Denominated Debt [Member]      
Foreign currency-denominated debt designated as net investment hedge: [Abstract]      
Net gain (loss) recognized in AOCI (32) 3 3
Foreign Currency Denominated Debt [Member] | Gain on business divestitures      
Foreign currency-denominated debt designated as net investment hedge: [Abstract]      
Net gain (loss) reclassified from AOCI to earnings 0 26 0
Currency derivatives [Member]      
Currency derivatives designated as cash flow hedges: [Abstract]      
Net gain (loss) recognized in AOCI (9) 11 4
Currency derivatives [Member] | Sales [Member]      
Currency derivatives designated as cash flow hedges: [Abstract]      
Net gain (loss) reclassified from AOCI into earnings 10 12 37
Currency derivatives not designated as hedging instruments: [Abstract]      
Net gain (loss) recognized in earnings 2 0 (1)
Currency derivatives [Member] | Other Income (Expense), Net [Member]      
Currency derivatives not designated as hedging instruments: [Abstract]      
Net gain (loss) recognized in earnings (4) 8 16
Interest Rate Contract      
Currency derivatives designated as cash flow hedges: [Abstract]      
Net gain (loss) recognized in AOCI $ 0 $ 0 $ (1)
v3.25.1
Derivative Financial Instruments and Hedging Activities (Fair Value of Derivatives in a Gain (Loss) Position) (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Apr. 30, 2024
Fair values of derivative instruments    
Derivative Asset, Fair Value, Gross Asset $ 4 $ 12
Derivative Liability, Fair Value, Gross Liability (14) (4)
Currency derivatives [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Other Current Assets [Member]    
Fair values of derivative instruments    
Derivative Asset, Fair Value, Gross Asset   11
Derivative Liability, Fair Value, Gross Liability   (2)
Currency derivatives [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Other Assets [Member]    
Fair values of derivative instruments    
Derivative Asset, Fair Value, Gross Asset   1
Derivative Liability, Fair Value, Gross Liability   (1)
Currency derivatives [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Accrued expenses [Member]    
Fair values of derivative instruments    
Derivative Asset, Fair Value, Gross Asset 2  
Derivative Liability, Fair Value, Gross Liability (11)  
Currency derivatives [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Other Liabilities [Member]    
Fair values of derivative instruments    
Derivative Asset, Fair Value, Gross Asset 0  
Derivative Liability, Fair Value, Gross Liability (3)  
Currency derivatives [Member] | Not designated as hedges [Member] | Other Current Assets [Member]    
Fair values of derivative instruments    
Derivative Asset, Fair Value, Gross Asset 2  
Derivative Liability, Fair Value, Gross Liability $ 0  
Currency derivatives [Member] | Not designated as hedges [Member] | Accrued expenses [Member]    
Fair values of derivative instruments    
Derivative Asset, Fair Value, Gross Asset   0
Derivative Liability, Fair Value, Gross Liability   $ (1)
v3.25.1
Derivative Financial Instruments and Hedging Activities (Textual) (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Derivative Instruments and Hedging Activities [Line Items]    
Maximum Remaining Maturity of Foreign Currency Derivatives 24 months 24 months
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months $ (8)  
Derivative, Net Liability Position, Aggregate Fair Value 12 $ 1
Finlandia    
Derivative Instruments and Hedging Activities [Line Items]    
Net investment hedge gain (Note 16) 26  
Foreign Exchange Contract [Member]    
Derivative Instruments and Hedging Activities [Line Items]    
Derivative, Notional Amount 463 566
Designated as Hedging Instrument [Member] | Net Investment Hedging [Member]    
Derivative Instruments and Hedging Activities [Line Items]    
Debt Instrument, Face Amount 531 497
4.75% senior notes, due April 15, 2033 {Member}    
Derivative Instruments and Hedging Activities [Line Items]    
Debt Instrument, Face Amount $ 650 $ 650
v3.25.1
Derivative Financial Instruments and Hedging Activities Offsetting Derivative Assets and Liabilities (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Apr. 30, 2024
Offsetting Assets and Liabilities [Line Items]    
Gross Amount of Derivative Assets $ 4 $ 12
Gross Amount of Derivative Liabilities Offset Against Derivative Assets in Balance Sheet (2) (3)
Net Amount of Derivative Assets Presented in Balance Sheet 2 9
Gross Amount of Derivative Liabilities Not Offset Against Derivative Assets in Balance Sheet 0 0
Net Amount of Derivative Assets 2 9
Gross Amount of Derivative Liabilities (14) (4)
Gross Amount of Derivative Assets Offset Against Derivative Liabilities in Balance Sheet 2 3
Net Amount of Derivative Liabilities Presented in Balance Sheet (12) (1)
Gross Amount of Derivative Assets Not Offset Against Derivative Liabilities in Balance Sheet 0 0
Net Amount of Derivative Liabilities $ (12) $ (1)
DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag true  
v3.25.1
Fair Value Measurements Fair Value Measurements (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Assets:      
Cash and cash equivalents, Carrying Amount $ 444 $ 446 $ 374
Cash and cash equivalents, Fair Value 444 446  
Liabilities:      
Contingent consideration, Carrying Amount 31 69  
Short-term borrowings, Carrying Amount 312 428  
Short-term borrowings, Fair Value 312 428  
Long-term debt (including current portion), Carrying Amount 2,421 2,672  
Fair Value, Inputs, Level 2 [Member]      
Assets:      
Currency derivatives, Fair Value 2 9  
Liabilities:      
Currency derivatives, Fair Value 12 1  
Long-term debt (including current portion), Fair Value 2,255 2,468  
Fair Value, Inputs, Level 3 [Member]      
Liabilities:      
Contingent consideration, Fair Value 31 69  
Foreign Exchange Contract [Member]      
Assets:      
Currency derivatives, Carrying Amount 2 9  
Liabilities:      
Currency derivatives, Carrying Amount $ 12 $ 1  
v3.25.1
Rollforward of Contingent Consideration (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Beginning balance $ 69 $ 63
Purchase accounting adjustment   (1)
Change in fair value [1] (43) 9
Foreign currency translation adjustment 5 (2)
Ending balance $ 31 $ 69
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Other income (expense), net Other income (expense), net
[1] Classified as “other expense (income), net” in the accompanying consolidated statement of operations.
v3.25.1
Impairment Charges (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Fair Value Disclosures [Abstract]      
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $ 47 $ 7 $ 96
v3.25.1
Leases ROU Assets and Liabilities (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Apr. 30, 2024
Leases [Abstract]    
Right-of-use assets $ 101 $ 96
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]    
Lease Liabilities:    
Current $ 26 $ 24
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]    
Non-current $ 78 $ 73
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]    
Total $ 104 $ 97
Weighted-average discount rate 4.50% 4.20%
Weighted-average remaining term 4 years 9 months 18 days 5 years 1 month 6 days
v3.25.1
Leases Lease Cost and Other Information (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Leases [Abstract]      
Total lease cost [1] $ 45 $ 51 $ 38
Cash paid for amounts included in the measurement of lease liabilities [2] 30 29 25
Right-of-use assets obtained in exchange for new lease liabilities $ 33 $ 38 $ 29
[1] Consists primarily of operating lease cost. Other components of lease cost were not material.
[2] Classified within operating activities in the accompanying consolidated statements of cash flows.
v3.25.1
Leases Future Operating Lease Payments (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Apr. 30, 2024
Leases [Abstract]    
2026 $ 30  
2027 27  
2028 20  
2029 16  
2030 12  
Thereafter 10  
Total lease payments 115  
Less: Present value discount (11)  
Lease liabilities $ 104 $ 97
v3.25.1
Other Comprehensive Income Schedule of Other Comprehensive Income (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Before Tax:      
Net other comprehensive income (loss) $ (16) $ 15 $ 113
Tax Effect:      
Net other comprehensive income (loss) 17 (1) 4
Net of Tax:      
Net other comprehensive income (loss) 1 14 117
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]      
Before Tax:      
Net gain (loss) 9 (16) 135
Reclassification to earnings 0 [1] 4 0
Net other comprehensive income (loss) 9 (12) 135
Tax Effect:      
Net gain (loss) 10 (1) 0
Reclassification to earnings 0 6 0
Net other comprehensive income (loss) 10 5 0
Net of Tax:      
Net gain (loss) 19 (17) 135
Reclassification to earnings 0 10 0
Net other comprehensive income (loss) 19 (7) 135
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent      
Before Tax:      
Net gain (loss) (9) 11 3
Reclassification to earnings [2] (10) (12) (37)
Net other comprehensive income (loss) (19) (1) (34)
Tax Effect:      
Net gain (loss) 2 (2) (1)
Reclassification to earnings 2 3 8
Net other comprehensive income (loss) 4 1 7
Net of Tax:      
Net gain (loss) (7) 9 2
Reclassification to earnings (8) (9) (29)
Net other comprehensive income (loss) (15) 0 (27)
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]      
Before Tax:      
Net gain (loss) (8) 22 (26)
Reclassification to earnings [3] 2 6 38
Net other comprehensive income (loss) (6) 28 12
Tax Effect:      
Net gain (loss) 3 (5) 6
Reclassification to earnings 0 (2) (9)
Net other comprehensive income (loss) 3 (7) (3)
Net of Tax:      
Net gain (loss) (5) 17 (20)
Reclassification to earnings 2 4 29
Net other comprehensive income (loss) $ (3) $ 21 $ 9
[1] Pre-tax amount is classified in gain on business divestitures in the accompanying consolidated statements of operations.
[2] Pre-tax amount is classified as sales in the accompanying consolidated statements of operations.
[3] Pre-tax amount is classified as non-operating postretirement expense in the accompanying consolidated statements of operations.
v3.25.1
Segment and Other Information (Net Sales by Geography) (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Geographic Areas, Revenues from External Customers [Abstract]      
Net sales $ 3,975 $ 4,178 $ 4,228
United States      
Geographic Areas, Revenues from External Customers [Abstract]      
Net sales 1,765 1,889 1,968
Mexico      
Geographic Areas, Revenues from External Customers [Abstract]      
Net sales 267 290 244
Germany      
Geographic Areas, Revenues from External Customers [Abstract]      
Net sales 253 263 239
Australia      
Geographic Areas, Revenues from External Customers [Abstract]      
Net sales 199 204 221
United Kingdom      
Geographic Areas, Revenues from External Customers [Abstract]      
Net sales 174 185 207
Other      
Geographic Areas, Revenues from External Customers [Abstract]      
Net sales [1] $ 1,317 $ 1,347 $ 1,349
[1] Includes net sales of (a) branded products to countries not listed above; (b) branded products to global duty-free customers, other travel retail customers, and the U.S. military, regardless of customer location; and (c) used barrels, contract bottling services, and non-branded bulk whiskey, regardless of customer location.
v3.25.1
Segment and Other Information (Major Customers) (Details) - Revenue from Contract with Customer, Product and Service Benchmark [Member] - Customer Concentration Risk
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
Largest Customer [Member]      
Percentage of Net Sales from Major Customers [Abstract]      
Concentration Risk, Percentage 13.00% 13.00% 14.00%
Second Largest Customer [Member]      
Percentage of Net Sales from Major Customers [Abstract]      
Concentration Risk, Percentage 11.00% 11.00% 12.00%
v3.25.1
Segment and Other Information (PP&E) (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Apr. 30, 2024
Property, Plant and Equipment [Abstract]    
Property, Plant and Equipment, Net $ 1,095 $ 1,074
Non-US [Member]    
Property, Plant and Equipment [Abstract]    
Property, Plant and Equipment, Net $ 283 $ 255
v3.25.1
Assets Held for Sale (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]    
Disposal Group, Including Discontinued Operation, Assets, Current $ 121 $ 0
Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current 33  
Disposal Group, Including Discontinued Operation, Inventory, Current 88  
Impairment of Long-Lived Assets to be Disposed of 2  
Inventory Write-down $ 3  
v3.25.1
Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2023
SEC Schedule, 12-09, Allowance, Credit Loss [Member]      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period $ 8 $ 7 $ 13
Additions Charged to Costs and Expenses 2 1 0
Additions Charged to Other Accounts 0 0 0
Deductions 3 [1] 0 6 [1]
Balance at End of Period 7 8 7
SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 16 14 27
Additions Charged to Costs and Expenses 7 2 4
Additions Charged to Other Accounts 14 2 0
Deductions 2 2 17
Balance at End of Period $ 35 $ 16 $ 14
[1] Doubtful accounts written off, net of recoveries.